<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">Autoimmun Rev</span><span class="iso-abbrev" title="iso-abbrev">Autoimmun Rev</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">Autoimmunity Reviews</span></div><span class="issn-ppub" tagx="issn" title="issn-ppub">1568-9972</span><span class="issn-epub" tagx="issn" title="issn-epub">1873-0183</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">The Author(s). Published by Elsevier B.V.</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7198427">7198427</a></span><span class="publisher-id" title="publisher-id">S1568-9972(20)30116-6</span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1016/j.autrev.2020.102554">10.1016/j.autrev.2020.102554</a></span><span class="publisher-id" title="publisher-id">102554</span><div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Article</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
Convalescent plasma in Covid-19: Possible mechanisms of action</div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rojas</span><span class="given-names" tagx="given-names" title="given-names">Manuel</span></span><a href="#af0005">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">RodrÃ­guez</span><span class="given-names" tagx="given-names" title="given-names">Yhojan</span></span><a href="#af0005">a</a><a href="#af0010">b</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Monsalve</span><span class="given-names" tagx="given-names" title="given-names">Diana M.</span></span><a href="#af0005">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Acosta-Ampudia</span><span class="given-names" tagx="given-names" title="given-names">Yeny</span></span><a href="#af0005">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Camacho</span><span class="given-names" tagx="given-names" title="given-names">Bernardo</span></span><a href="#af0015">c</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gallo</span><span class="given-names" tagx="given-names" title="given-names">Juan Esteban</span></span><a href="#af0020">d</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rojas-Villarraga</span><span class="given-names" tagx="given-names" title="given-names">Adriana</span></span><a href="#af0025">e</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">RamÃ­rez-Santana</span><span class="given-names" tagx="given-names" title="given-names">Carolina</span></span><a href="#af0005">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">DÃ­az-Coronado</span><span class="given-names" tagx="given-names" title="given-names">Juan C.</span></span><a href="#af0030">f</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Manrique</span><span class="given-names" tagx="given-names" title="given-names">RubÃ©n</span></span><a href="#af0035">g</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mantilla</span><span class="given-names" tagx="given-names" title="given-names">Ruben D.</span></span><a href="#af0005">a</a><a href="#af0010">b</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shoenfeld</span><span class="given-names" tagx="given-names" title="given-names">Yehuda</span></span><a href="#af0040">h</a><a href="#af0045">i</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Anaya</span><span class="given-names" tagx="given-names" title="given-names">Juan-Manuel</span></span><span class="email" tagx="email" title="email">juan.anaya@urosario.edu.co</span><a href="#af0005">a</a><a href="#af0010">b</a><a href="#cr0005">â�Ž</a></span><span class="citation_author_institution" id="af0005">[a], </span><span class="citation_author_institution" id="af0010">[b], </span><span class="citation_author_institution" id="af0015">[c], </span><span class="citation_author_institution" id="af0020">[d], </span><span class="citation_author_institution" id="af0025">[e], </span><span class="citation_author_institution" id="af0030">[f], </span><span class="citation_author_institution" id="af0035">[g], </span><span class="citation_author_institution" id="af0040">[h], </span><span class="citation_author_institution" id="af0045">[i], </span></div> <div class="author-notes" title="author-notes"> <div class="corresp" title="corresp"><span class="label" tagx="label" title="label">â�Ž</span>Corresponding author at: Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Carrera 26-63-B-51, 110010 Bogota, Colombia. <span class="email" tagx="email" title="email">juan.anaya@urosario.edu.co</span></div> </div><span class="pub-date-pmc-release" title="pub-date-pmc-release">pmc-release: <span>2020-5-5</span></span><span class="pub-date-ppub" title="pub-date-ppub">ppub: <span>2020-7</span></span><span class="pub-date-epub" title="pub-date-epub">epub: <span>2020-5-5</span></span><span class="volume" tagx="volume" title="volume">19</span><span class="issue" tagx="issue" title="issue">7</span><span class="fpage" tagx="fpage" title="fpage">102554</span><span class="lpage" tagx="lpage" title="lpage">102554</span><span class="history" title="history"><span class="received" title="received">received: 2020-4-11</span></span><div class="permissions"><span class="copyright" title="copyright">(C) , <span class="copyright-year" tagx="copyright-year" title="copyright-year">2020</span></span><span class="license" title="license"><span class="license-p" title="license-p">Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</span></span></div> <div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible of the coronavirus disease 2019 (COVID-19) pandemic. Therapeutic options including antimalarials, antivirals, and vaccines are under study. Meanwhile the current pandemic has called attention over old therapeutic tools to treat infectious diseases. Convalescent plasma (CP) constitutes the first option in the current situation, since it has been successfully used in other coronaviruses outbreaks. Herein, we discuss the possible mechanisms of action of CP and their repercussion in COVID-19 pathogenesis, including direct neutralization of the virus, control of an overactive immune system (<i>i.e.</i>, cytokine storm, Th1/Th17 ratio, complement activation) and immunomodulation of a hypercoagulable state. All these benefits of CP are expected to be better achieved if used in non-critically hospitalized patients, in the hope of reducing morbidity and mortality.</p> </div> <div class="abstract" title="abstract"> <div class="title" tagx="title" title="title">
Highlights</div> <p> </p><ul> <li><span class="label" tagx="label" title="label">â€¢</span><p id="p0005">Coronavirus disease 19 (COVID-19) is an emerging viral threat with major repercussions for public health.</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="p0010">There is not specific treatment for COVID-19.</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="p0015">Convalescent plasma (CP) emerges as the first option of management for hospitalized patients with COVID-19.</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="p0020">Transference of neutralizing antibodies helps to control COVID-19 infection and modulates inflammatory response.</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="p0025">Other plasma components may enhance the antiviral and anti-inflammatory properties of CP.</p> </li> </ul> <p /> </div> <div class="kwd-group"> <div class="title" tagx="title" title="title">
Keywords</div> <div class="kwd" title="kwd">
Coronavirus</div> <div class="kwd" title="kwd">
COVID-19</div> <div class="kwd" title="kwd">
SARS-Cov-2</div> <div class="kwd" title="kwd">
Convalescent plasma</div> <div class="kwd" title="kwd">
Cytokines</div> <div class="kwd" title="kwd">
Intravenous immunoglobulins</div> <div class="kwd" title="kwd">
Neutralizing antibodies</div> <div class="kwd" title="kwd">
ACE-2 receptor</div> </div> <div class="kwd-group"> <div class="title" tagx="title" title="title">
Abbreviations</div> <div class="kwd" title="kwd">
2019-nCoV, 2019 novel coronavirus</div> <div class="kwd" title="kwd">
ACE-2, Angiotensin converting enzyme-2</div> <div class="kwd" title="kwd">
ADE, Antibody-dependent enhancement</div> <div class="kwd" title="kwd">
BAFF, B cellâ€"activating factor</div> <div class="kwd" title="kwd">
BCR, B-cell receptor</div> <div class="kwd" title="kwd">
COVID-19, Coronavirus disease 2019</div> <div class="kwd" title="kwd">
CP, Convalescent plasma</div> <div class="kwd" title="kwd">
DCs, Dendritic cells</div> <div class="kwd" title="kwd">
E, Envelope</div> <div class="kwd" title="kwd">
HIV, Human immunodeficiency virus</div> <div class="kwd" title="kwd">
ICU, Intensive care unit</div> <div class="kwd" title="kwd">
IgG, Immunoglobulin G</div> <div class="kwd" title="kwd">
IgM, Immunoglobulin M</div> <div class="kwd" title="kwd">
IVIg, Intravenous immunoglobulin</div> <div class="kwd" title="kwd">
M, Membrane</div> <div class="kwd" title="kwd">
MERS, Middle East respiratory syndrome</div> <div class="kwd" title="kwd">
MERS-CoV, MERS coronavirus</div> <div class="kwd" title="kwd">
N, Nucleoprotein</div> <div class="kwd" title="kwd">
NAbs, Neutralizing antibodies</div> <div class="kwd" title="kwd">
NAT, Nucleic acid test</div> <div class="kwd" title="kwd">
S1-RBD, Spike1-receptor binding protein</div> <div class="kwd" title="kwd">
SARS, Severe acute respiratory syndrome coronavirus</div> <div class="kwd" title="kwd">
SARS-CoV, SARS coronavirus.</div> </div> </div> </div> <div class="body" title="body"> <div class="introduction" title="sec"><span class="label" tagx="label" title="label">1</span><div class="title" tagx="title" title="title">
Introduction</div> <p id="p0030">Viruses of the <i>Coronaviridae</i> family have a positive-sense, single strand, RNA structure with 26 to 32 kilobases length [<a href="#bb0005">1</a>]. Coronaviruses have been recognized in numerous avian hosts and in several mammals, such bats, camels, mice, cats, dogs and more recently in scaly anteaters [<a href="#bb0010">[2]</a>, <a href="#bb0015">[3]</a>, <a href="#bb0020">[4]</a>]. Most of Coronaviruses are pathogenic to humans but they produce mild symptoms or asymptomatic infections. However, in the last two decades two lethal viruses have emerged within this family: the severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) [<a href="#bb0025">5</a>], and the Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV) [<a href="#bb0030">6</a>]. These are characterized by severe fever (85%), non-productive cough (69%), myalgia (49%) and dyspnea (42%), with a high frequency of admission to intensive care unit (ICU) [<a href="#bb0025">5</a>,<a href="#bb0035">7</a>].</p> <p id="p0035">In December 2019, a new member of the <i>Coronaviridae</i> family associated with severe pneumonia was detected in Wuhan, China [<a href="#bb0040">8</a>]. Patients showed similar clinical findings to SARS-CoV and MERS-CoV given by high fever, dyspnea, and chest radiographs revealing invasive multilobed lesions [<a href="#bb0045">9</a>,<a href="#bb0050">10</a>]. The virus was initially termed as 2019 novel coronavirus (2019-nCoV) [<a href="#bb0040">8</a>], and it is currently known as SARS-CoV-2 producing the coronavirus disease 2019 (COVID-19). The origin of the virus is unknown, however, a recent study showed that the virus shares 88% identity with bat-derived SARS-like coronaviruses named bat-SL-CoVZC45 and bat-SL-CoVZXC21, suggesting that bats are the most likely reservoir [<a href="#bb0020">4</a>]. Interestingly, phylogenetic analysis revealed that SARS-CoV and MERS-CoV were close to COVID-19 in about 79% and 50%, respectively. Recently, it has been discussed that the similar sequence of the virus with human proteins could be deleterious and associated with autoimmune phenomena [<a href="#bb0055">11</a>,<a href="#bb0060">12</a>]. Although the current situation argues for prompt vaccination strategies, it has been suggested that it would be safer to test cross-reactivity of different viral antigens with those in humans to reduce the probability of autoimmune reactions (<i>i.e.</i>, molecular mimicry), especially in individuals with genetic background for autoimmunity [<a href="#bb0055">11</a>,<a href="#bb0065">13</a>].</p> <p id="p0040">Currently, treatment of disease is challenging and the lack of clinical evidence with antiviral agents is the rule. Therapeutic schemes with Lopinavir/Ritonavir failed to prove reduction in overall mortality [<a href="#bb0070">14</a>]. A recent randomized controlled trial with Hydroxychloroquine, showed reduction in body temperature and cough remission in the intervention group compared with controls [<a href="#bb0075">15</a>]. However, the small sample size and the short period of follow up, preclude conclusions about its efficacy. Other study suggested that Azithromycin plus Hydroxychloroquine may reduce viral load, nonetheless, the clinical response associated with this approach was not evaluated and remains to be defined [<a href="#bb0080">16</a>]. This combination was recently associated to worse outcomes when Hydroxychloroquine was administrated at high doses (QTc elongation and higher rates of lethality) [<a href="#bb0085">17</a>]. Thus, there is not an effective nor safe medication for the management of COVID-19.</p> <p id="p0045">Given the lack of evidence for treatment of COVID-19 and vaccines, classical and historical interventions have remerged as options for the control of disease. That is the case of convalescent plasma (CP), a strategy of passive immunization that has been used in prevention and management of infectious diseases since early 20th century [<a href="#bb0090">18</a>]. The CP is obtained using apheresis in survivors with prior infections caused by pathogens of interest in whom antibodies against the causal agent of disease are developed. The major target is to neutralize the pathogen for its eradication [<a href="#bb0095">19</a>]. Given its rapid obtaining, CP has been considered as an emergency intervention in several pandemics, including the Spanish flu, SARS-CoV, West Nile virus, and more recently, Ebola virus [<a href="#bb0100">[20]</a>, <a href="#bb0105">[21]</a>, <a href="#bb0110">[22]</a>, <a href="#bb0115">[23]</a>, <a href="#bb0120">[24]</a>]. CP early administered after symptoms onset showed a reduction in mortality compared with placebo or no therapy in severe acute respiratory infections of viral etiology like influenza and SARS-CoV, however, a similar response in Ebola virus disease was not observed [<a href="#bb0100">20</a>,<a href="#bb0125">25</a>].</p> <p id="p0050">During apheresis, in addition to neutralizing antibodies (NAbs), other proteins such as anti-inflammatory cytokines, clotting factors, natural antibodies, defensins, pentraxins and other undefined proteins are obtained from donors [<a href="#bb0130">26</a>]. In this sense, transfusion of CP to infected patients may provide further benefits such as immunomodulation <i>via</i> amelioration of severe inflammatory response [<a href="#bb0135">27</a>]. The latter could be the case of COVID-19 in which an over-activation of the immune system may come with systemic hyper-inflammation or â€œcytokine stormâ€� driven by IL-1Î², IL-2, IL-6, IL-17, IL-8, TNFÎ± and CCL2. This inflammatory reaction may perpetuate pulmonary damage entailing fibrosis and reduction of pulmonary capacity [<a href="#bb0140">28</a>,<a href="#bb0145">29</a>]. Herein, we propose the likely beneficial mechanisms of administering CP to patients with COVID-19 and provide a summary of evidence of this strategy in the current pandemic. At the proof stage of this article there were 56 clinical trials registered at <a href="http://www.clinicaltrials.gov">www.clinicaltrials.gov</a>, including ours (<a href="NCT04332835">NCT04332835</a>, <a href="NCT04332380">NCT04332380</a>), in which the role of CP in COVID-19 will be evaluated.</p> </div> <div class="productionandcomposition" title="sec"><span class="label" tagx="label" title="label">2</span><div class="title" tagx="title" title="title">
Production and composition</div> <div class="historicalperspective" title="sec"><span class="label" tagx="label" title="label">2.1</span><div class="title" tagx="title" title="title">
Historical perspective</div> <p id="p0055">The principle of CP infusion was established in 1880 when it was shown that immunity against diphtheria relied on existing antibodies in blood from animals intentionally immunized with non-lethal doses of toxins, that could be transferred to animals suffering from active infections [<a href="#bb0150">30</a>,<a href="#bb0155">31</a>]. Then, it was recognized that immune plasma not only neutralizes the pathogen, but also provides passive immunomodulatory properties that allow the recipient to control the excessive inflammatory cascade induced by several infectious agents or sepsis [<a href="#bb0130">26</a>,<a href="#bb0155">31</a>]. In the early 1950s, purification and concentration of immunoglobulins from healthy donors or recovered patients provided an option to treat serious infectious diseases as well as immune conditions including primary immunodeficiencies, allergies, and autoimmune diseases [<a href="#bb0150">30</a>,<a href="#bb0160">32</a>,<a href="#bb0165">33</a>].</p> <p id="p0060">Several convalescent blood products such as intravenous immunoglobulins (IVIg) and polyclonal or monoclonal antibodies have been developed to treat infectious conditions [<a href="#bb0090">18</a>]. However, in situations of emergency, they are difficult and expensive to produce, and may not yield an appropriate infectious control. Thus, the use of CP has been widely used in different outbreaks as the first therapeutic option given the lack of effective medications or vaccines, and often as last chance or experimental treatment [<a href="#bb0130">26</a>].</p> <p id="p0065">From the Spanish influenza to the current pandemic caused by SARS-Cov-2, it has been observed that the use of CP significantly reduces the case fatality rates. That is the case of Influenza A (H1N1) pdm09, Spanish Influenza A (H1N1), and SARS-CoV infections in which the use of CP was associated to reduction in fatality rates, mortality (<a href="#t0005">Table 1</a> ) [<a href="#bb0025">5</a>,<a href="#bb0170">[34]</a>, <a href="#bb0175">[35]</a>, <a href="#bb0180">[36]</a>, <a href="#bb0185">[37]</a>, <a href="#bb0190">[38]</a>, <a href="#bb0195">[39]</a>, <a href="#bb0200">[40]</a>, <a href="#bb0205">[41]</a>, <a href="#bb0210">[42]</a>, <a href="#bb0215">[43]</a>, <a href="#bb0220">[44]</a>, <a href="#bb0225">[45]</a>,<a href="#bib551">111</a>], and mild adverse events (<a href="#t0010">Table 2</a> ) [<a href="#bb0125">25</a>,<a href="#bb0230">[46]</a>, <a href="#bb0235">[47]</a>, <a href="#bb0240">[48]</a>, <a href="#bb0245">[49]</a>]. Furthermore, the use of CP in other coronaviruses such as SARS-CoV, reduced days of hospital stay in critically ill patients [<a href="#bb0210">42</a>,<a href="#bb0250">50</a>]. In relation to the use of mechanical ventilation, in Influenza A (H1N1) pdm09, and avian influenza A (H5N1), administration of CP reduced the duration of invasive ventilation [<a href="#bb0235">47</a>,<a href="#bb0255">51</a>]. In addition, it has been described that the use of CP in SARS-CoV and avian influenza A (H5N1) decreased the viral load in the respiratory tract [<a href="#bb0230">46</a>,<a href="#bb0245">49</a>]. Currently, CP used in patients with COVID-19 demonstrated to reduce viral load and improve clinical condition [<a href="#bb0190">38</a>,<a href="#bb0195">39</a>]. However, it is necessary to conduct randomized controlled trials to confirm the usefulness of this intervention in both hospitalized patients with mild/severe symptoms and those in ICU. <div class="table-wrap_UNKNOWN" position="float" id="t0005"><span class="label" tagx="label" title="label">Table 1</span> </div></p><p>Convalescent plasma in patients with respiratory infection by Coronavirus (SARS, MERS, and COVID-19).</p>  <div tag="alt-text">
Table 1</div> <table frame="hsides" rules="groups"> <thead> <tr> <th>Author</th> <th>Country</th> <th>Study design</th> <th>Viral Etiology</th> <th>Diagnosis</th> <th>Individuals included</th> <th>Non-CP treatment</th> <th>Previous clinical state CP</th> <th>Dose protocol CP</th> <th>Intervention</th> <th>Outcomes</th> <th>Mortality</th> </tr> </thead> <tbody> <tr> <td>Zhang et al. (2020) <a href="#bib551">[111]</a></td> <td>China</td> <td>Case series</td> <td>COVID-19</td> <td>RT-PCR</td> <td>Intervention: 4</td> <td>Lopinavir/Ritonavir, Interferon alpha-2b, oseltamivir, Ribavirin</td> <td>Clinical deterioration</td> <td>Unknown</td> <td>200â€"400 mL in one or two consecutive transfusions. A patient received 2,400 mL divided in eight consecutive transfusions</td> <td>Clinical recovery and discharge from hospital</td> <td>0% intervention group</td> </tr> <tr> <td>Shen et al. (2020) [<a href="#bb0190">38</a>]</td> <td>China</td> <td>Case series</td> <td>COVID-19</td> <td>RT-PCR</td> <td>Intervention: 5</td> <td>All patients received antiviral management during treatment.</td> <td>Clinical deterioration</td> <td>CP from the same donor</td> <td>CP 200â€"250Â mL two consecutive transfusions CP 200Â mL single dose</td> <td>Improvement in viral load and increase in antibodies</td> <td>0% intervention group</td> </tr> <tr> <td>Duan et al. (2020) [<a href="#bb0195">39</a>]</td> <td>China</td> <td>Clinical trial</td> <td>COVID-19</td> <td>RT-PCR</td> <td>Intervention: 19</td> <td>Ribavirin, Cefoperazone, Levoflaxacin, Methylprednisolone, Interferon, Peramivir, Caspofungin.</td> <td>Clinical deterioration</td> <td>CP from the same donor</td> <td>CP 200Â mL single dose</td> <td>Viral load improvement and lung imaging</td> <td>Reduction of viral load and improvement in lung images</td> </tr> <tr> <td>Ye et al. (2020) [<a href="#bb0185">37</a>]</td> <td>China</td> <td>Case series</td> <td>COVID-19</td> <td>RT-PCR</td> <td>Intervention: 6</td> <td>Not reported</td> <td>Clinical deterioration</td> <td>Unknown</td> <td>CP 200â€"250Â mL two consecutive transfusions</td> <td>Reduction of viral load and increase of SARS-CoV-2 IgG and IgM antibodies</td> <td>0% intervention group</td> </tr> <tr> <td>Anh et al. (2020) [<a href="#bb0170">34</a>]</td> <td>South Korea</td> <td>Case report</td> <td>COVID-19</td> <td>RT-PCR</td> <td>Intervention: 2</td> <td>Lopinavir/Ritonavir, hydroxychloroquine and empirical antibiotics</td> <td>Clinical deterioration</td> <td>Unknown</td> <td>Unknown</td> <td>Reduction of viral load and increase of SARS-CoV-2 IgG and IgM antibodies</td> <td>0% intervention group</td> </tr> <tr> <td rowspan="2">Soo <i>et al</i> (2004) [<a href="#bb0200">40</a>]</td> <td rowspan="2">China</td> <td rowspan="2">Retrospective comparison of cases</td> <td rowspan="2">SARS-CoV</td> <td rowspan="2">CDC Case Definition</td> <td rowspan="2">Intervention: 19, control: 21</td> <td>Intervention Group: Ribavirin, 3 doses Methylprednisolone (1 âˆ™ 5Â g).</td> <td rowspan="2">Clinical deterioration</td> <td rowspan="2">Unknown</td> <td rowspan="2">CP 200â€"400Â mLÂ days 11 and 42 after the onset of symptoms</td> <td rowspan="2">Mortality, length of hospital stay, adverse events</td> <td rowspan="2">23% reduction (<i>p</i>Â =Â .03)</td> </tr> <tr> <td>Control group: Ribavirin, 4 or more doses of Methylprednisolone (1 âˆ™ 5Â g).</td> </tr> <tr> <td>Cheng <i>et al</i> (2005) [<a href="#bb0205">41</a>]</td> <td>China</td> <td>Case series</td> <td>SARS-CoV</td> <td>CDC case definition and serology</td> <td>Intervention: 80</td> <td>Unknown</td> <td>Clinical deterioration</td> <td>Unknown</td> <td>CP 279Â mL per day 14</td> <td>Mortality, length of hospital stay</td> <td>12.5% intervention group</td> </tr> <tr> <td>Nie et al. (2003) [<a href="#bb0025">5</a>]</td> <td>China</td> <td>Case series</td> <td>SARS-CoV</td> <td>Unknown</td> <td>Intervention: 40</td> <td>Unknown</td> <td>Unknown</td> <td>Unknown</td> <td>CP unknown dose</td> <td>Mortality</td> <td>0% intervention group</td> </tr> <tr> <td>Yeh <i>et al</i> (2005) [<a href="#bb0210">42</a>]</td> <td>Taiwan</td> <td>Case series</td> <td>SARS-CoV</td> <td>Serology</td> <td>Intervention: 3</td> <td>Ribavirin, Moxifloxacin, Methylprednisolone</td> <td>Clinical deterioration</td> <td>Unknown</td> <td>CP unknown dose on day 11 of symptom onset</td> <td>Mortality, antibodies, viral load, adverse events</td> <td>0% intervention group</td> </tr> <tr> <td>Zhou et al. (2003) [<a href="#bb0215">43</a>]</td> <td>China</td> <td>Case series</td> <td>SARS-CoV</td> <td>CDC case definition</td> <td>Intervention: 1 control: 28</td> <td>All patients received Ribavirin, Azithromycin, Levofloxacin, Steroids, Mechanical ventilation.</td> <td>Vulnerable or comorbid older adults</td> <td>Unknown</td> <td>CP 50Â mL single dose on day 17 of symptom onset</td> <td>Mortality, length of hospital stay</td> <td>7% reduction (<i>p</i>Â =Â .93)</td> </tr> <tr> <td>Kong (2003) [<a href="#bb0220">44</a>]</td> <td>China (Hong Kong)</td> <td>Case report</td> <td>SARS-CoV</td> <td>Clinical Diagnosis</td> <td>Intervention: 1</td> <td>Antivirals, Steroids, Ventilation</td> <td>Clinical deterioration</td> <td>CP from the same donor</td> <td>CP 250Â mL 2 doses day 7 of the onset of symptoms</td> <td>Mortality</td> <td>0% intervention group</td> </tr> <tr> <td>Wong <i>et al</i> (2003) [<a href="#bb0225">45</a>]</td> <td>China (Hong Kong)</td> <td>Case report</td> <td>SARS-CoV</td> <td>WHO case definition</td> <td>Intervention: 1</td> <td>Ribavirin, Oseltamivir, Cefotaxime, Levofloxacin</td> <td>Clinical deterioration</td> <td>CP from the same donor</td> <td>200Â mL CP on day 14 of symptom onset</td> <td>Mortality</td> <td>0% intervention group</td> </tr> <tr> <td>Ko et al. (2018) [<a href="#bb0175">35</a>]</td> <td>South Korea</td> <td>Case series</td> <td>MERS-CoV</td> <td>RT-PCR</td> <td>Intervention: 3</td> <td>Steroids</td> <td>Clinical deterioration</td> <td>Unknown</td> <td>CP unspecified dose</td> <td>Antibody titers</td> <td>0% intervention group</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>CDC: Centers for disease control and prevention; COVID-19: Coronavirus disease 2019; CP: Convalescent plasma; MERS-CoV: Middle East respiratory syndrome coronavirus; mL: Millilitres; IgM: Immunoglobulin M; IgG: Immunoglobulin G; NA: Not available; RT PCR: Real-time polymerase chain reaction; SARS-CoV: Severe acute respiratory syndrome coronavirus; WHO: World health organization. Taken and modified from [<a href="#bb0100">20</a>].</p> </div> </div>  <div class="table-wrap_UNKNOWN" position="float" id="t0010"><span class="label" tagx="label" title="label">Table 2</span> <p>Associated adverse events to convalescent plasma in different epidemics.</p>  <div tag="alt-text">
Table 2</div> <table frame="hsides" rules="groups"> <thead> <tr> <th>Author</th> <th>Country</th> <th>Viral etiology</th> <th>Adverse events</th> </tr> </thead> <tbody> <tr> <td>Zhang; et al. (2020) <a href="#bib551">[111]</a></td> <td>China</td> <td>COVID-19</td> <td>None</td> </tr> <tr> <td>Shen et al. (2020) [<a href="#bb0190">38</a>]</td> <td>China</td> <td>COVID-19</td> <td>None</td> </tr> <tr> <td>Duan et al. (2020) [<a href="#bb0195">39</a>]</td> <td>China</td> <td>COVID-19</td> <td>Self-limited facial erythema in 2/10 patients. No major adverse events.</td> </tr> <tr> <td>Ye et al. (2020) [<a href="#bb0185">37</a>]</td> <td>China</td> <td>COVID-19</td> <td>None</td> </tr> <tr> <td>Anh et al. (2020) [<a href="#bb0170">34</a>]</td> <td>South Korea</td> <td>COVID-19</td> <td>None</td> </tr> <tr> <td>Soo et al (2004) [<a href="#bb0200">40</a>]</td> <td>China</td> <td>SARS-CoV</td> <td>None</td> </tr> <tr> <td>Cheng et al (2005) [<a href="#bb0205">41</a>]</td> <td>China</td> <td>SARS-CoV</td> <td>None</td> </tr> <tr> <td>Nie et al. (2003) [<a href="#bb0025">5</a>]</td> <td>China</td> <td>SARS-CoV</td> <td>None</td> </tr> <tr> <td>Yeh et al (2005) [<a href="#bb0210">42</a>]</td> <td>Taiwan</td> <td>SARS-CoV</td> <td>None</td> </tr> <tr> <td>Zhou et al. (2003) [<a href="#bb0215">43</a>]</td> <td>China</td> <td>SARS-CoV</td> <td>None</td> </tr> <tr> <td>Kong et al. (2003) [<a href="#bb0220">44</a>]</td> <td>China</td> <td>SARS-CoV</td> <td>None</td> </tr> <tr> <td>Wong et al (2003) [<a href="#bb0225">45</a>]</td> <td>China</td> <td>SARS-CoV</td> <td>None</td> </tr> <tr> <td>Ko et al. (2018) [<a href="#bb0175">35</a>]</td> <td>South Korea</td> <td>MERS-CoV</td> <td>None</td> </tr> <tr> <td>Van Griensven et al. (2016) [<a href="#bb0125">25</a>]</td> <td>Guinea</td> <td>Ebola</td> <td>Nausea, skin erythema, fever. No major adverse events.</td> </tr> <tr> <td>Hung et al. (2011) [<a href="#bb0230">46</a>]</td> <td>China</td> <td>Influenza A(H1N1)</td> <td>None</td> </tr> <tr> <td>Chan et al. (2010) [<a href="#bb0235">47</a>]</td> <td>China</td> <td>Influenza A(H1N1)</td> <td>None</td> </tr> <tr> <td>Yu et al. (2008) [<a href="#bb0240">48</a>]</td> <td>China</td> <td>Influenza A(H5N1)</td> <td>None</td> </tr> <tr> <td>Kong et al. (2006) [<a href="#bb0245">49</a>]</td> <td>China</td> <td>Influenza A(H5N1)</td> <td>None</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>COVID-19: Coronavirus disease 2019; MERS-CoV: Middle East respiratory syndrome coronavirus; SARS-CoV: Severe acute respiratory syndrome coronavirus.</p> </div> </div> </div> <p /> <p id="p0070">The safety of the use of CP is another issue that has been historically relevant in epidemics. Currently, evidence exists of the safety of CP in situations of emergency (<a href="#t0010">Table 2</a>). In epidemics of Influenza A (H1N1), SARS-CoV and MERS-CoV, studies did not find any adverse event associated to CP administration. In the case of Ebola, CP administration was associated with mild adverse reactions such as nausea, skin erythema, and fever [<a href="#bb0125">25</a>]. In COVID-19, reports have shown that administration of CP is safe, and it was not associated with major adverse events. Thus, due to tolerability and potential efficacy, CP is a good candidate to be evaluated as a therapeutic option to control the current pandemic.</p> </div> <div class="acquisitionandplasmacomposition" title="sec"><span class="label" tagx="label" title="label">2.2</span><div class="title" tagx="title" title="title">
Acquisition and plasma composition</div> <p id="p0075">The convalescent donors must undergo standard pre-donation assessment to ensure compliance with current regulations regarding plasma donation [<a href="#bb0260">52</a>]. Currently, convalescent donors between 18 and 65 are considered as subjects without infectious symptomatology and a negative test for COVID-19 after 14Â days of recovery. These tests must be repeated 48Â h later and at the moment of donation [<a href="#bb0195">39</a>,<a href="#bb0260">52</a>]. Donors from endemic areas for tropical diseases (<i>e.g.</i>, malaria) should be excluded. In addition to molecular tests, it is critical to recognize the emotional situation, to explore susceptibilities, and guarantee not exploitation of donors [<a href="#bb0265">53</a>].</p> <p id="p0080">Apheresis is the recommended procedure to obtain plasma. This procedure is based on a continuous centrifugation of blood from donor to allow a selective collection plasma. The efficiency of this technique is around 400â€"800Â mL from a single apheresis donation. This amount of plasma could be storage in units of 200 or 250Â mL, and frozen within 24Â h of collection to be used in further transfusions [<a href="#bb0270">54</a>].</p> <p id="p0085">As CP production requires high quality standards, it must be free of any infection, so tests for human immunodeficiency virus (HIV), hepatitis B, hepatitis C, syphilis, human T-cell lymphotropic virus 1 and 2, and <i>Trypanosoma cruzi</i> (if living in an endemic area) should be carried out [<a href="#bb0260">52</a>,<a href="#bb0275">55</a>]. In this sense, the nucleic acid test for HIV and hepatitis viruses is mandatory to guarantee the safety of recipients [<a href="#bb0280">56</a>]. Other protocols suggest the inactivation of pathogens with riboflavin or psoralen plus exposure to ultraviolet light to improve safety of CP [<a href="#bb0285">57</a>].</p> <p id="p0090">There is not a standard transfusion dose of CP. In different studies for coronaviruses the administration of CP ranges between 200 and 500Â mL in single or double scheme dosages (<a href="#t0005">Table 1</a>). Currently, the recommendation is to administrate 3Â mL/kg per dose in two days [<a href="#bb0270">54</a>]. This strategy facilitates the distribution of plasma units (250Â mL per unit) and provide a standard option of delivery in public health strategies.</p> <p id="p0095">Composition of CP is variable and include a wide variety of blood derive components. Plasma contains a mixture of inorganic salts, organic compounds, water, and more than 1000 proteins. In the latter we found albumin, immunoglobulins, complement, coagulation and antithrombotic factors among others [<a href="#bb0290">58</a>] (<a href="#f0005">Fig. 1</a>A). Interestingly, it is supposed that plasma from healthy donors provides immunomodulatory effects <i>via</i> the infusion of anti-inflammatory cytokines and antibodies that blockade complement, inflammatory cytokines and autoantibodies [<a href="#bb0135">27</a>]. These factors may influence the immunomodulatory effect of CP in patients with COVID-19 (see below for details). </p><div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Fig. 1</span></a></div>   <p>Schematic representation of convalescent plasma components and its mechanisms of action. <b>A.</b> Main convalescent plasma components. <b>B.</b> Antiviral effects of NAbs. IgG and IgM are the main isotypes, although IgA may be also important, particularly in mucosal viral infections. Other non-NAbs may exert a protective effect. The humoral immune response is mainly directed towards spike (S) protein. <b>C.</b> Anti-inflammatory effects of CP include network of autoantibodies and control of an overactive immune system (<i>i.e.</i>, cytokine storm, Th1/Th17 ratio, complement activation and regulation of a hypercoagulable state) (see text for details). N: Nucleoprotein; M: Membrane; E: Envelope.</p>   </div> <p /> </div> </div> <div class="antiviralmechanisms" title="sec"><span class="label" tagx="label" title="label">3</span><div class="title" tagx="title" title="title">
Antiviral mechanisms</div> <p id="p0100">NAbs are crucial in virus clearance and have been considered essential in protecting against viral diseases. Passive immunity driven by CP can provide these NAbs that restrain the infection. The efficacy of this therapy has been associated with the concentration of NAbs in plasma from recovered donors <a href="#bb0125">[25]</a>, <a href="#bib552">[112]</a>. In SARS-CoV and MERS was discovered that NAbs bind to spike1-receptor binding protein (S1-RBD), S1-N-terminal domain and S2, thus inhibiting their entry, limiting viral amplification [<a href="#bb0295">59</a>]. Moreover, other antibody-mediated pathways such as complement activation, antibody-dependent cellular cytotoxicity and/or phagocytosis may also promote the therapeutic effect of CP.</p> <p id="p0105">Tian et al. [<a href="#bb0300">60</a>], showed through ELISA and Biolayer Interferometry Binding that one SARS-CoV-specific antibody, CR3022, bind with COVID-19 RBD and more importantly this antibody did not show any competition with angiotensin converting enzyme-2 (ACE-2) for the binding to COVID-19 RBD. The RBD of COVID-19 varies broadly from the SARS-CoV at the C-terminus residues. Although this difference does not enable COVID-19 to bind ACE-2 receptor, does influence the cross-reactivity of NAbs [<a href="#bb0300">60</a>].</p> <p id="p0110">A pseudotyped-lentiviral-vector-based neutralization assay to measure specific NAbs in plasma from recovered patients with SARS-CoV-2 showed variations in NAbs titers, approximately 30% of patients did not develop high NAbs titers after infection [<a href="#bb0305">61</a>]. These variations are associated with age, lymphocyte count, and C reactive protein levels in blood, suggesting that other components from plasma contribute to the recovery of these patients.</p> <p id="p0115">In plasma, in addition to NAbs, there are other protective antibodies, including immunoglobulin G (IgG) and immunoglobulin M (IgM). Non-NAbs that bind to the virus, but do not affect its capacity to replicate, might contribute to prophylaxis and/or recovery improvement [<a href="#bb0270">54</a>] (<a href="#f0005">Fig. 1</a>B).</p> <p id="p0120">SARS-CoV infection induces IgG antibodies production against nucleoprotein (N) that can be detected at day 4 after the onset of disease and with seroconversion at day 14 [<a href="#bb0310">62</a>]. In SARS infection 89% of the recovered patients, showed IgG-specific and NAbs 2Â years post infection [<a href="#bb0315">63</a>]. Moreover, the highest concentration of IgM was detected on the ninth day after the onset of disease and class switching to IgG occurred in the second week [<a href="#bb0320">64</a>].</p> <p id="p0125">Shen et al. [<a href="#bb0190">38</a>], showed that recovered donors from COVID-19 infection had SARS-CoV-2â€"specific antibody titers ranging between 1.800 and 16.200 and NAbs titers were between 80 and 480. The plasma obtained from the donors and transfused in the recipients on the same day lead to viral load decreased. After transfusion of CP, the titers of IgG and IgM in the recipients increased in a time-dependent manner. Moreover, presence of NAbs in the recipients played a vital role in the restriction of viral infection. Another study evaluated the kinetics of SARS-CoV-2-specific NAbs development during the course of the disease. The titers of NAbs in patients infected with SARS-CoV-2 were low before day 10 post-disease onset and then increased, with a peak 10 to 15Â days after disease onset, remaining stable thereafter in all patients [<a href="#bb0305">61</a>].</p> </div> <div class="immunomodulation" title="sec"><span class="label" tagx="label" title="label">4</span><div class="title" tagx="title" title="title">
Immunomodulation</div> <div class="f(abÂ´)2mechanisms" title="sec"><span class="label" tagx="label" title="label">4.1</span><div class="title" tagx="title" title="title">
F(abÂ´)2 mechanisms</div> <p id="p0130">Historically, administration of IVIg has been one of the critical interventions in patients with autoimmune diseases as well as in autoinflammatory diseases, transplantation (<i>i.e.</i>, chronic graft <i>vs.</i> host disease after marrow transplantation), primary and secondary immunodeficiency, hematologic malignancies among other conditions. Preparation of IVIg includes anti-idiotypic antibodies that blockade autoreactive recipient antibodies [<a href="#bb0180">36</a>,<a href="#bb0325">65</a>]. This reaction is critical to control autoantibodies in patients with autoimmune diseases. In this sense, a recent report in patients with COVID-19, showed that critically ill patients exhibited positivity for anti-cardiolipin IgA antibodies as well as for antiâ€"Î²2-glycoprotein I IgA and IgG antibodies [<a href="#bb0330">66</a>]. This evidence may suggest that CP-COVID-19 may neutralize this type of autoantibodies reducing the odds of suffering from thrombotic events (<i>i.e.</i>, antiphospholipid syndrome-like disease), especially in critically ill patients. In the same line, a recent report of a patient with SjÃ¶gren's syndrome and COVID-19 successfully treated with CP may suggest that this strategy is safe and effective in autoimmune conditions [<a href="#bb0185">37</a>].</p> <p id="p0135">In addition, some antibodies inhibit complement cascade (<i>i.e.</i>, C3a and C5a), and limit the formation of immune complexes (<a href="#f0005">Fig. 1</a>C) [<a href="#bb0335">67</a>,<a href="#bb0340">68</a>]. Complement-deficient mice with induced SARS-CoV infection showed high viral titers, secretion of inflammatory cytokines and chemokines, and immune cell infiltration within the lung. These results suggest that complement activation largely contribute to systemic inflammation and migration of neutrophils to the lungs, perpetuating tissue damage [<a href="#bb0345">69</a>]. Additional studies have shown that IgG transferred by plasma neutralize cytokines such as IL-1Î² and TNFÎ± [<a href="#bb0350">70</a>]. In this sense, passive immunity by infusion of CP-COVID-19 may limit the inflammatory cascade driven by pathogenic antibodies, as well as the cellular damage induced by the complement cascade activation in excessive inflammatory environments.</p> <p id="p0140">Antibody-dependent enhancement (ADE) is a mechanism in which the intensity of infection increases in the presence of preexisting poorly NAbs, favoring the replication of virus into macrophages and other cells through interaction with Fc and/or complement receptors [<a href="#bb0355">71</a>]. This phenomenon is used by feline coronaviruses, HIV and dengue viruses to take advantage of prior anti-viral humoral immune response to effectively infect host target cells [<a href="#bb0360">72</a>,<a href="#bb0365">73</a>]. <i>In vitro</i> assays with human promonocyte cell lines demonstrated that SARS-CoV ADE was primarily mediated by antibodies against spike proteins, significantly increasing the rate of apoptosis in these cells [<a href="#bb0365">73</a>]. This is of major interest in regions in which coronaviruses are endemic. Vaccines development should consider this phenomenon in patients with COVID-19, and administration of CP-COVID-19 in these areas should be conducted with caution since ADE may emerge as a harmful reaction in patients with active infection [<a href="#bb0370">74</a>]. If one suspects of this phenomenon following CP-COVID-19 administration, clinicians must promptly notify the health authorities and evaluate the safety according to endemic coronaviruses in the region.</p> </div> <div class="fcmechanisms" title="sec"><span class="label" tagx="label" title="label">4.2</span><div class="title" tagx="title" title="title">
Fc mechanisms</div> <p id="p0145">FcRn is a critical regulator of IgG half-life. This receptor works by preventing degradation and clearance of IgG, by a pinocytotic mechanism that allow antibody circulation within the cell for its posterior excretion [<a href="#bb0325">65</a>,<a href="#bb0375">75</a>]. The FcRn inhibitor rozanolixizumab showed reduction of IgG concentrations in a phase 1 study [<a href="#bb0380">76</a>], and it proved to be critical in IVIg catabolism in common variable immunodeficiency patients [<a href="#bb0385">77</a>]. It has been demonstrated that saturation of this receptor by IVIg may account as the most likely mechanism to clear autoantibodies in autoimmune conditions by shortening their lifetime [<a href="#bb0390">[78]</a>, <a href="#bb0395">[79]</a>, <a href="#bb0400">[80]</a>]. Whether antibodies play a critical role in COVID-19 pathogenesis stills remain to be elucidated, however, the saturation of FcRn may provide an additional immunomodulatory pathway in patients receiving CP.</p> <p id="p0150">FcÎ³ receptors are found in about all immune cells. These receptors are critical factors in modulating or inhibiting activity of immune cells, including lymphocytes [<a href="#bb0375">75</a>]. FcÎ³ receptor activation by IgG induces the upregulation of FCÎ³RIIB which has been associated with inhibitory effects. This was demonstrated in B cells, where the upregulation of FCÎ³RIIB was associated with treatment efficacy for acute rejection after kidney transplantation [<a href="#bb0405">81</a>], and was a key determinant for IVIg response in patients with Kawasaki disease [<a href="#bb0410">82</a>]. It has been suggested that sialylation of this receptor is critical for inhibitory effects in immune cells [<a href="#bb0415">83</a>]. However, the study of Th17 cells in autoimmune encephalomyelitis model revealed that this process is dispensable for the immunomodulatory effect of IVIg treatment [<a href="#bb0420">84</a>]. Despite these results, CP infusion may help the modulation of immune response <i>via</i> FcÎ³ receptors, and merits attention in the current management of COVID-19.</p> </div> <div class="dendriticcells" title="sec"><span class="label" tagx="label" title="label">4.3</span><div class="title" tagx="title" title="title">
Dendritic cells</div> <p id="p0155">Dendritic cells (DCs) are key regulators of innate immunity and work as specialized antigen presenting cells. <i>In vitro</i> studies have shown that administration of IVIg may abrogate maturation of DCs, as well as a reduction in the production of IL-12. Interestingly, the production of IL-10 was enhanced [<a href="#bb0425">85</a>]. In the study conducted by Sharma et al. [<a href="#bb0430">86</a>], authors found that IVIg induced the production of IL-33 that subsequently expands IL-4-producing basophils. In this line, other study found that IVIg could promote the production of IL-4 and IL-13 which correlated with levels of IL-33 [<a href="#bb0435">87</a>]. A Th2 cytokine-mediated downregulation of FcÎ³RIIa and IFN-Î³R2 was suggested to be the most likely mechanisms for this phenomenon. Recently, it was found that IVIg activates Î²-catenin in an IgG-sialylation independent manner, which is critical for reducing inflammation [<a href="#bb0440">88</a>].</p> <p id="p0160">Down regulation of HLA-II and costimulation molecules such CD86, CD80, and CD40 have been reported in DCs after stimulation with IVIg [<a href="#bb0425">85</a>]. In patients with systemic lupus erythematosus, which show a high proinflammatory environment, administration of IVIg abrogated IFN-Î±-mediated maturation [<a href="#bb0445">89</a>,<a href="#bb0450">90</a>]. All together, data suggest that infusion of plasma from recovered COVID-19 donors may enhance anti-inflammatory properties of DCs, which could be critical in phases of excessive inflammatory stimuli in patients with COVID-19.</p> </div> <div class="tcells" title="sec"><span class="label" tagx="label" title="label">4.4</span><div class="title" tagx="title" title="title">
T cells</div> <p id="p0165">Despite the ability of enhancing Th2 <i>via</i> IL-33 in DCs [<a href="#bb0435">87</a>], it has been described that IVIg modulates the balance between CD4<sup>+</sup>/CD8<sup>+</sup> T cells, as well as promoting proliferation and survival of Tregs. Treatment with IVIg seems to reduce antigenic presentation of T cells <i>via</i> the modulation and inhibition of DCs. This process was independent of FCÎ³RIIB [<a href="#bb0455">91</a>], and other reports showed that reduced activation of T cells was independent of IgG sialylation, monocytes or B cells [<a href="#bb0460">92</a>].</p> <p id="p0170">In addition, patients treated with IVIg showed a reduction in Th1 cells and low levels of IFNÎ³ and TNFÎ± with the increase of Th2 cytokines such as IL-4 and IL-10 [<a href="#bb0465">93</a>]. Clinically, it has been demonstrated that patients with Influenza A (H1N1) treated with CP exhibited a reduction of IL-6 and TNFÎ± [<a href="#bb0470">94</a>], with an increase of IL-10 [<a href="#bb0230">46</a>]. This support the notion of an anti-inflammatory effect of CP in subjects with acute viral infections.</p> <p id="p0175">Cytotoxicity is also regulated by administration of IVIg. In the study of Klehmet et al. [<a href="#bb0475">95</a>], authors found that patients with chronic inflammatory demyelinating polyneuropathy treated with IVIg, showed reduction in CD8<sup>+</sup> T cells with high levels of CD4<sup>+</sup> T effector memory and T central memory cells. In another study, IVIg proved to reduce the activation of CD8<sup>+</sup> T cells associated with a T-cell receptor blockade, thus reducing the interaction between effector and target cells [<a href="#bb0480">96</a>]. In subjects with Kawasaki disease, a high proportion of CD8<sup>+</sup> was associated with resistance to IVIg, thus suggesting that these cells could be considered a predictive factor for IVIg response [<a href="#bb0485">97</a>].</p> <p id="p0180">Recent studies have shown that IVIg reduces the proliferation of Th17 cells, as well as decreases the production of IL-17A, IL-17F, IL-21, and CCL20 [<a href="#bb0490">98</a>,<a href="#bb0495">99</a>]. In other study, IVIg appeared to modulate the Th17/Treg ratio which is associated with recurrent pregnancy loss [<a href="#bb0500">100</a>]. It is plausible that CP may act in a similar way in patients with COVID-19 [<a href="#bb0140">28</a>,<a href="#bb0145">29</a>] (<a href="#f0005">Fig. 1</a>C).</p> </div> <div class="bcells" title="sec"><span class="label" tagx="label" title="label">4.5</span><div class="title" tagx="title" title="title">
B cells</div> <p id="p0185">B cells are critical in adaptive immunity <i>via</i> production of antibodies and cytokines. In patients with demyelinating polyneuropathy, administration of IVIg was associated with overexpression of FcÎ³RIIB receptors on B cells [<a href="#bb0505">101</a>,<a href="#bb0510">102</a>]. IVIg abrogated TLR-9-dependent B cell responses. This was associated with IVIg inhibitions of NF-ÎºB signaling pathway, reduction of CD25 and CD40 expression, and reduction of IL-6 and IL-10 production by B cells. This process seems to be regulated by SH2 domainâ€"containing phosphatase 1 [<a href="#bb0515">103</a>].</p> <p id="p0190">Proliferation and survival of B cells is mediated by the B cellâ€"activating factor (BAFF). In the study conducted by Le Pottier et al. [<a href="#bb0520">104</a>], authors found that IVIg contained NAbs for BAFF. This could explain the reduction in proliferation, as well as the increased rates of apoptosis of B cells. Regarding the latter process, it was found that anti-Fas (anti-CD95) antibodies, present in IVIg preparations, induced apoptosis in B cells [<a href="#bb0525">105</a>].</p> <p id="p0195">In DCs, downregulation of costimulatory molecules following administration of IVIg has been observed. This is similar to B cells which exhibited a reduction in antigen-presentation activity secondary to IgG internalization, in concordance with a reduced IL-2 production by T cells [<a href="#bb0530">106</a>]. Moreover, IVIg administration modulates B-cell receptor (BCR) signaling. In the study of SÃ©Ã¯tÃ© et al. [<a href="#bb0535">107</a>], authors found that interaction between BCR and CD22 resulted in a down-regulation of tyrosine phosphorylation of Lyn and the B-cell linker proteins which resulted in a sustained activation of Erk 1/2 and arrest of the cell cycle at the G/1 phase.</p> <p id="p0200">These mechanisms may account for immunomodulation of the inflammatory response in COVID-19 secondary to CP administration. As showed above, recent reports suggest the production of antiphospholipid antibodies in patients with COVID-19 together with an antiphospholipid-like syndrome [<a href="#bb0330">66</a>], and the regulation of this cascade could be critical to avoid deleterious outcomes in these group of patients (<i>i.e.</i>, thrombosis, disseminated intravascular coagulopathy).</p> </div> <div class="otherimmunecells" title="sec"><span class="label" tagx="label" title="label">4.6</span><div class="title" tagx="title" title="title">
Other immune cells</div> <p id="p0205">The major immunological factor suspected to be associated with inflammation and lung damage in COVID-19 is the activation of macrophages. It has been suggested that patients with COVID-19 may suffer from a macrophage activation syndrome-like disease associated to innate immune migration to lung tissues [<a href="#bb0140">28</a>]. In this context, the inhibition of this immunological pathway may help to control excessive cytokine production and prevent pulmonary damage (<i>i.e.</i>, fibrosis). This was recently supported by the study of Blanco-Melo et al. [<a href="#bb0540">108</a>] who described an up regulation of chemokines for innate immune cells in ferrets as well as in patients with COVID-19. Interestingly, results suggest that this scenario mainly occurred in the first 7Â days post infection, whereas at day 14th, other cytokines such as IL-6 and IL-1 persisted activated [<a href="#bb0540">108</a>]. These data have critical therapeutic consequences.</p> <p id="p0210">In the study conducted by Kozicky et al. [<a href="#bb0545">109</a>], authors found that macrophages treated with IVIg showed an increased production of IL-10, with a reduction in IL-12/23p40, thus suggesting the promotion of an anti-inflammatory macrophage profile. Although there is no evidence of macrophage pulmonary migration inhibition by IVIg, a study on induced peripheral neurotoxicity showed that this treatment reduced nerve macrophage infiltration in rats [<a href="#bb0550">110</a>]. These observations deserve attention in those patients treated with CP-COVID-19 since they may account for the positive results encountered in critically ill patients with COVID-19 [<a href="#bb0190">38</a>,<a href="#bb0195">39</a>]. In this line, we argue for CP-COVID-19 administration in early stages of diseases to prevent innate immune cells migration and avoid lung damage.</p> </div> </div> <div class="conclusions" title="sec"><span class="label" tagx="label" title="label">5</span><div class="title" tagx="title" title="title">
Conclusions</div> <p id="p0215">CP is a safe and potentially effective strategy for the treatment of emerging and re-emerging pathogens, especially in those scenarios without proved antiviral agents or vaccines. IVIg and CP shared similar mechanisms of action. The potential antiviral and immunomodulatory effects of CP are currently evaluated in COVID-19. According to the physiopathology of COVID-19 severe patients should be privileged over critical ones in order to reduce mortality and improve outcomes.</p> </div> <div class="funding" title="sec"> <div class="title" tagx="title" title="title">
Funding</div> <p id="p0220">This work was supported by </p><div class="funding-source" title="funding-source"> <div class="institution-wrap" title="institution-wrap"><span class="institution-id" title="institution-id">10.13039/501100008793</span><span class="institution" title="institution">Universidad del Rosario</span></div> </div> (ABN-011), Bogota, and <div class="funding-source" title="funding-source">
Universidad CES (Office of Research and Innovation)</div>, Medellin, Colombia.<p /> </div> </div> <div class="back" title="back"> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
References</div> <li tag="ref"><a name="bb0005" /><span class="label" tagx="label" title="label">1</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Su</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wong</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shi</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lai</span><span class="given-names" tagx="given-names" title="given-names">A.C.K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Epidemiology, genetic recombination, and pathogenesis of coronaviruses</span><span class="source" tagx="source" title="source">Trends Microbiol</span><span class="volume" tagx="volume" title="volume">24</span><span class="year" tagx="year" title="year">2016</span><span class="fpage" tagx="fpage" title="fpage">490</span><span class="lpage" tagx="lpage" title="lpage">502</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.tim.2016.03.003">10.1016/j.tim.2016.03.003</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27012512">27012512</a></span></span></li> <li tag="ref"><a name="bb0010" /><span class="label" tagx="label" title="label">2</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cavanagh</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Coronavirus avian infectious bronchitis virus</span><span class="source" tagx="source" title="source">Vet Res</span><span class="volume" tagx="volume" title="volume">38</span><span class="year" tagx="year" title="year">2007</span><span class="fpage" tagx="fpage" title="fpage">281</span><span class="lpage" tagx="lpage" title="lpage">297</span><span class="pub-id"><a href="https://dx.doi.org/10.1051/vetres:2006055">10.1051/vetres:2006055</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17296157">17296157</a></span></span></li> <li tag="ref"><a name="bb0015" /><span class="label" tagx="label" title="label">3</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ismail</span><span class="given-names" tagx="given-names" title="given-names">M.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tang</span><span class="given-names" tagx="given-names" title="given-names">A.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Saif</span><span class="given-names" tagx="given-names" title="given-names">Y.M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Pathogenicity of turkey coronavirus in turkeys and chickens</span><span class="source" tagx="source" title="source">Avian Dis</span><span class="volume" tagx="volume" title="volume">47</span><span class="year" tagx="year" title="year">2003</span><span class="fpage" tagx="fpage" title="fpage">515</span><span class="lpage" tagx="lpage" title="lpage">522</span><span class="pub-id"><a href="https://dx.doi.org/10.1637/5917">10.1637/5917</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14562877">14562877</a></span></span></li> <li tag="ref"><a name="bb0020" /><span class="label" tagx="label" title="label">4</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lu</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Niu</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding</span><span class="source" tagx="source" title="source">Lancet</span><span class="volume" tagx="volume" title="volume">395</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">565</span><span class="lpage" tagx="lpage" title="lpage">574</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/S0140-6736(20)30251-8">10.1016/S0140-6736(20)30251-8</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32007145">32007145</a></span></span></li> <li tag="ref"><a name="bb0025" /><span class="label" tagx="label" title="label">5</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nie</span><span class="given-names" tagx="given-names" title="given-names">Q.-H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Luo</span><span class="given-names" tagx="given-names" title="given-names">X.-D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hui</span><span class="given-names" tagx="given-names" title="given-names">W.-L.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Advances in clinical diagnosis and treatment of severe acute respiratory syndrome</span><span class="source" tagx="source" title="source">World J Gastroenterol</span><span class="volume" tagx="volume" title="volume">9</span><span class="year" tagx="year" title="year">2003</span><span class="fpage" tagx="fpage" title="fpage">1139</span><span class="lpage" tagx="lpage" title="lpage">1143</span><span class="pub-id"><a href="https://dx.doi.org/10.3748/wjg.v9.i6.1139">10.3748/wjg.v9.i6.1139</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12800213">12800213</a></span></span></li> <li tag="ref"><a name="bb0030" /><span class="label" tagx="label" title="label">6</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zaki</span><span class="given-names" tagx="given-names" title="given-names">A.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">van Boheemen</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bestebroer</span><span class="given-names" tagx="given-names" title="given-names">T.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Osterhaus</span><span class="given-names" tagx="given-names" title="given-names">A.D.M.E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fouchier</span><span class="given-names" tagx="given-names" title="given-names">R.A.M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia</span><span class="source" tagx="source" title="source">N Engl J Med</span><span class="volume" tagx="volume" title="volume">367</span><span class="year" tagx="year" title="year">2012</span><span class="fpage" tagx="fpage" title="fpage">1814</span><span class="lpage" tagx="lpage" title="lpage">1820</span><span class="pub-id"><a href="https://dx.doi.org/10.1056/NEJMoa1211721">10.1056/NEJMoa1211721</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23075143">23075143</a></span></span></li> <li tag="ref"><a name="bb0035" /><span class="label" tagx="label" title="label">7</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Phua</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Weng</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ling</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Egi</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lim</span><span class="given-names" tagx="given-names" title="given-names">C.-M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Divatia</span><span class="given-names" tagx="given-names" title="given-names">J.V.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Intensive care management of coronavirus disease 2019 (COVID-19): Challenges and recommendations</span><span class="source" tagx="source" title="source">Lancet Respir Med</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/S2213-2600(20)30161-2">10.1016/S2213-2600(20)30161-2</a></span></span></li> <li tag="ref"><a name="bb0040" /><span class="label" tagx="label" title="label">8</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhu</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Song</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">A novel coronavirus from patients with pneumonia in China, 2019</span><span class="source" tagx="source" title="source">N Engl J Med</span><span class="volume" tagx="volume" title="volume">382</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">727</span><span class="lpage" tagx="lpage" title="lpage">733</span><span class="pub-id"><a href="https://dx.doi.org/10.1056/NEJMoa2001017">10.1056/NEJMoa2001017</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31978945">31978945</a></span></span></li> <li tag="ref"><a name="bb0045" /><span class="label" tagx="label" title="label">9</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chan</span><span class="given-names" tagx="given-names" title="given-names">J.F.-W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yuan</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kok</span><span class="given-names" tagx="given-names" title="given-names">K.-H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">To</span><span class="given-names" tagx="given-names" title="given-names">K.K.-W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chu</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster</span><span class="source" tagx="source" title="source">Lancet</span><span class="volume" tagx="volume" title="volume">395</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">514</span><span class="lpage" tagx="lpage" title="lpage">523</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/S0140-6736(20)30154-9">10.1016/S0140-6736(20)30154-9</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31986261">31986261</a></span></span></li> <li tag="ref"><a name="bb0050" /><span class="label" tagx="label" title="label">10</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ren</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</span><span class="source" tagx="source" title="source">Lancet</span><span class="volume" tagx="volume" title="volume">395</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">497</span><span class="lpage" tagx="lpage" title="lpage">506</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/S0140-6736(20)30183-5">10.1016/S0140-6736(20)30183-5</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31986264">31986264</a></span></span></li> <li tag="ref"><a name="bb0055" /><span class="label" tagx="label" title="label">11</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shoenfeld</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Corona (COVID-19) time musings: Our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning</span><span class="source" tagx="source" title="source">Autoimmun Rev</span><span class="volume" tagx="volume" title="volume">102538</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.autrev.2020.102538">10.1016/j.autrev.2020.102538</a></span></span></li> <li tag="ref"><a name="bb0060" /><span class="label" tagx="label" title="label">12</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kanduc</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shoenfeld</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span></span><span class="mixed-article-title" title="mixed-article-title">On the molecular determinants and the mechanism of the SARS-CoV-2 attack 2020</span><span class="source" tagx="source" title="source">Clin Immunol</span><span class="volume" tagx="volume" title="volume">215</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">108426</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.clim.2020.108426">10.1016/j.clim.2020.108426</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32311462">32311462</a></span></span></li> <li tag="ref"><a name="bb0065" /><span class="label" tagx="label" title="label">13</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rojas</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Restrepo-JimÃ©nez</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Monsalve</span><span class="given-names" tagx="given-names" title="given-names">D.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pacheco</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Acosta-Ampudia</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">RamÃ­rez-Santana</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Molecular mimicry and autoimmunity</span><span class="source" tagx="source" title="source">J Autoimmun</span><span class="volume" tagx="volume" title="volume">95</span><span class="year" tagx="year" title="year">2018</span><span class="fpage" tagx="fpage" title="fpage">100</span><span class="lpage" tagx="lpage" title="lpage">123</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.jaut.2018.10.012">10.1016/j.jaut.2018.10.012</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30509385">30509385</a></span></span></li> <li tag="ref"><a name="bb0070" /><span class="label" tagx="label" title="label">14</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cao</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wen</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fan</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span></span><span class="mixed-article-title" title="mixed-article-title">A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19</span><span class="source" tagx="source" title="source">N Engl J Med</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1056/NEJMoa2001282">10.1056/NEJMoa2001282</a></span></span></li> <li tag="ref"><a name="bb0075" /><span class="label" tagx="label" title="label">15</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jiang</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Han</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yan</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Efficacy of hydroxychloroquine in patients with COVID-19: Results of a randomized clinical trial</span><span class="source" tagx="source" title="source">MedRxiv</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1101/2020.03.22.20040758">10.1101/2020.03.22.20040758</a></span></span></li> <li tag="ref"><a name="bb0080" /><span class="label" tagx="label" title="label">16</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gautret</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lagier</span><span class="given-names" tagx="given-names" title="given-names">J.-C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Parola</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hoang</span><span class="given-names" tagx="given-names" title="given-names">V.T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Meddeb</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mailhe</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial</span><span class="source" tagx="source" title="source">Int J Antimicrob Agents</span><span class="volume" tagx="volume" title="volume">105949</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.ijantimicag.2020.105949">10.1016/j.ijantimicag.2020.105949</a></span></span></li> <li tag="ref"><a name="bb0085" /><span class="label" tagx="label" title="label">17</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Borba</span><span class="given-names" tagx="given-names" title="given-names">M.G.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Val</span><span class="given-names" tagx="given-names" title="given-names">F.F.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sampaio</span><span class="given-names" tagx="given-names" title="given-names">V.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Alexandre</span><span class="given-names" tagx="given-names" title="given-names">M.A.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Melo</span><span class="given-names" tagx="given-names" title="given-names">G.C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Brito</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A randomized clinical trial</span><span class="source" tagx="source" title="source">JAMA Netw Open</span><span class="volume" tagx="volume" title="volume">3</span><span class="year" tagx="year" title="year">2020</span>e208857<span class="pub-id"><a href="https://dx.doi.org/10.1001/jamanetworkopen.2020.8857">10.1001/jamanetworkopen.2020.8857</a></span></span></li> <li tag="ref"><a name="bb0090" /><span class="label" tagx="label" title="label">18</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Marano</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vaglio</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pupella</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Facco</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Catalano</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liumbruno</span><span class="given-names" tagx="given-names" title="given-names">G.M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Convalescent plasma: New evidence for an old therapeutic tool?</span><span class="source" tagx="source" title="source">Blood Transfus</span><span class="volume" tagx="volume" title="volume">14</span><span class="year" tagx="year" title="year">2016</span><span class="fpage" tagx="fpage" title="fpage">152</span><span class="lpage" tagx="lpage" title="lpage">157</span><span class="pub-id"><a href="https://dx.doi.org/10.2450/2015.0131-15">10.2450/2015.0131-15</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26674811">26674811</a></span></span></li> <li tag="ref"><a name="bb0095" /><span class="label" tagx="label" title="label">19</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Burnouf</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Seghatchian</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Ebola virus convalescent blood products: Where we are now and where we may need to go</span><span class="source" tagx="source" title="source">Transfus Apher Sci</span><span class="volume" tagx="volume" title="volume">51</span><span class="year" tagx="year" title="year">2014</span><span class="fpage" tagx="fpage" title="fpage">120</span><span class="lpage" tagx="lpage" title="lpage">125</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.transci.2014.10.003">10.1016/j.transci.2014.10.003</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25457751">25457751</a></span></span></li> <li tag="ref"><a name="bb0100" /><span class="label" tagx="label" title="label">20</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mair-Jenkins</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Saavedra-Campos</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Baillie</span><span class="given-names" tagx="given-names" title="given-names">J.K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cleary</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Khaw</span><span class="given-names" tagx="given-names" title="given-names">F.-M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lim</span><span class="given-names" tagx="given-names" title="given-names">W.S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: A systematic review and exploratory meta-analysis</span><span class="source" tagx="source" title="source">J Infect Dis</span><span class="volume" tagx="volume" title="volume">211</span><span class="year" tagx="year" title="year">2015</span><span class="fpage" tagx="fpage" title="fpage">80</span><span class="lpage" tagx="lpage" title="lpage">90</span><span class="pub-id"><a href="https://dx.doi.org/10.1093/infdis/jiu396">10.1093/infdis/jiu396</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25030060">25030060</a></span></span></li> <li tag="ref"><a name="bb0105" /><span class="label" tagx="label" title="label">21</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rojas</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Monsalve</span><span class="given-names" tagx="given-names" title="given-names">D.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pacheco</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Acosta-Ampudia</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">RamÃ­rez-Santana</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ansari</span><span class="given-names" tagx="given-names" title="given-names">A.A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Ebola virus disease: An emerging and re-emerging viral threat</span><span class="source" tagx="source" title="source">J Autoimmun</span><span class="volume" tagx="volume" title="volume">106</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">102375</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.jaut.2019.102375">10.1016/j.jaut.2019.102375</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31806422">31806422</a></span></span></li> <li tag="ref"><a name="bb0110" /><span class="label" tagx="label" title="label">22</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Planitzer</span><span class="given-names" tagx="given-names" title="given-names">C.B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Modrof</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kreil</span><span class="given-names" tagx="given-names" title="given-names">T.R.</span></span></span><span class="mixed-article-title" title="mixed-article-title">West Nile virus neutralization by US plasma-derived immunoglobulin products</span><span class="source" tagx="source" title="source">J Infect Dis</span><span class="volume" tagx="volume" title="volume">196</span><span class="year" tagx="year" title="year">2007</span><span class="fpage" tagx="fpage" title="fpage">435</span><span class="lpage" tagx="lpage" title="lpage">440</span><span class="pub-id"><a href="https://dx.doi.org/10.1086/519392">10.1086/519392</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17597458">17597458</a></span></span></li> <li tag="ref"><a name="bb0115" /><span class="label" tagx="label" title="label">23</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Haley</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Retter</span><span class="given-names" tagx="given-names" title="given-names">A.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fowler</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gea-Banacloche</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Oâ€™Grady</span><span class="given-names" tagx="given-names" title="given-names">N.P.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis</span><span class="source" tagx="source" title="source">Clin Infect Dis</span><span class="volume" tagx="volume" title="volume">37</span><span class="year" tagx="year" title="year">2003</span><span class="fpage" tagx="fpage" title="fpage">e88</span><span class="lpage" tagx="lpage" title="lpage">e90</span><span class="pub-id"><a href="https://dx.doi.org/10.1086/377172">10.1086/377172</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12955669">12955669</a></span></span></li> <li tag="ref"><a name="bb0120" /><span class="label" tagx="label" title="label">24</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shimoni</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Niven</span><span class="given-names" tagx="given-names" title="given-names">M.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pitlick</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bulvik</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Treatment of West Nile virus encephalitis with intravenous immunoglobulin</span><span class="source" tagx="source" title="source">Emerg Infect Dis</span><span class="volume" tagx="volume" title="volume">7</span><span class="year" tagx="year" title="year">2001</span><span class="fpage" tagx="fpage" title="fpage">759</span><span class="pub-id"><a href="https://dx.doi.org/10.3201/eid0704.010432">10.3201/eid0704.010432</a></span></span></li> <li tag="ref"><a name="bb0125" /><span class="label" tagx="label" title="label">25</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">van Griensven</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Edwards</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">de Lamballerie</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Semple</span><span class="given-names" tagx="given-names" title="given-names">M.G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gallian</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Baize</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Evaluation of convalescent plasma for Ebola virus disease in Guinea</span><span class="source" tagx="source" title="source">N Engl J Med</span><span class="volume" tagx="volume" title="volume">374</span><span class="year" tagx="year" title="year">2016</span><span class="fpage" tagx="fpage" title="fpage">33</span><span class="lpage" tagx="lpage" title="lpage">42</span><span class="pub-id"><a href="https://dx.doi.org/10.1056/NEJMoa1511812">10.1056/NEJMoa1511812</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26735992">26735992</a></span></span></li> <li tag="ref"><a name="bb0130" /><span class="label" tagx="label" title="label">26</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Garraud</span><span class="given-names" tagx="given-names" title="given-names">O.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Heshmati</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pozzetto</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lefrere</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Girot</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Saillol</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Plasma therapy against infectious pathogens, as of yesterday, today and tomorrow</span><span class="source" tagx="source" title="source">Transfus Clin Biol</span><span class="volume" tagx="volume" title="volume">23</span><span class="year" tagx="year" title="year">2016</span><span class="fpage" tagx="fpage" title="fpage">39</span><span class="lpage" tagx="lpage" title="lpage">44</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.tracli.2015.12.003">10.1016/j.tracli.2015.12.003</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26775794">26775794</a></span></span></li> <li tag="ref"><a name="bb0135" /><span class="label" tagx="label" title="label">27</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">LÃ¼nemann</span><span class="given-names" tagx="given-names" title="given-names">J.D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nimmerjahn</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dalakas</span><span class="given-names" tagx="given-names" title="given-names">M.C.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Intravenous immunoglobulin in neurology--mode of action and clinical efficacy</span><span class="source" tagx="source" title="source">Nat Rev Neurol</span><span class="volume" tagx="volume" title="volume">11</span><span class="year" tagx="year" title="year">2015</span><span class="fpage" tagx="fpage" title="fpage">80</span><span class="lpage" tagx="lpage" title="lpage">89</span><span class="pub-id"><a href="https://dx.doi.org/10.1038/nrneurol.2014.253">10.1038/nrneurol.2014.253</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25561275">25561275</a></span></span></li> <li tag="ref"><a name="bb0140" /><span class="label" tagx="label" title="label">28</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">McGonagle</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sharif</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Oâ€™Regan</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bridgewood</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease</span><span class="source" tagx="source" title="source">Autoimmun Rev</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.autrev.2020.102537">10.1016/j.autrev.2020.102537</a></span><span class="comment">In press:102537</span></span></li> <li tag="ref"><a name="bb0145" /><span class="label" tagx="label" title="label">29</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wan</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yi</span><span class="given-names" tagx="given-names" title="given-names">Q.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fan</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lv</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guo</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)</span><span class="source" tagx="source" title="source">MedRxiv</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1101/2020.02.10.20021832">10.1101/2020.02.10.20021832</a></span></span></li> <li tag="ref"><a name="bb0150" /><span class="label" tagx="label" title="label">30</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shahani</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Singh</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Khardori</span><span class="given-names" tagx="given-names" title="given-names">N.M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Immunotherapy in clinical medicine: Historical perspective and current status</span><span class="source" tagx="source" title="source">Med Clin North Am</span><span class="volume" tagx="volume" title="volume">96</span><span class="year" tagx="year" title="year">2012</span><span class="fpage" tagx="fpage" title="fpage">421</span><span class="lpage" tagx="lpage" title="lpage">431</span><span class="comment">ix</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.mcna.2012.04.001">10.1016/j.mcna.2012.04.001</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22703849">22703849</a></span></span></li> <li tag="ref"><a name="bb0155" /><span class="label" tagx="label" title="label">31</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shakir</span><span class="given-names" tagx="given-names" title="given-names">E.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cheung</span><span class="given-names" tagx="given-names" title="given-names">D.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Grayson</span><span class="given-names" tagx="given-names" title="given-names">M.H.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Mechanisms of immunotherapy: A historical perspective</span><span class="source" tagx="source" title="source">Ann Allergy Asthma Immunol</span><span class="volume" tagx="volume" title="volume">105</span><span class="year" tagx="year" title="year">2010</span><span class="fpage" tagx="fpage" title="fpage">340</span><span class="lpage" tagx="lpage" title="lpage">347</span><span class="comment">quiz 348, 368</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.anai.2010.09.012">10.1016/j.anai.2010.09.012</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21055659">21055659</a></span></span></li> <li tag="ref"><a name="bb0160" /><span class="label" tagx="label" title="label">32</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sherer</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Levy</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shoenfeld</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span></span><span class="mixed-article-title" title="mixed-article-title">IVIG in autoimmunity and cancer--efficacy versus safety</span><span class="source" tagx="source" title="source">Expert Opin Drug Saf</span><span class="volume" tagx="volume" title="volume">1</span><span class="year" tagx="year" title="year">2002</span><span class="fpage" tagx="fpage" title="fpage">153</span><span class="lpage" tagx="lpage" title="lpage">158</span><span class="pub-id"><a href="https://dx.doi.org/10.1517/14740338.1.2.153">10.1517/14740338.1.2.153</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12904149">12904149</a></span></span></li> <li tag="ref"><a name="bb0165" /><span class="label" tagx="label" title="label">33</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Katz</span><span class="given-names" tagx="given-names" title="given-names">U.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Achiron</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sherer</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shoenfeld</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Safety of intravenous immunoglobulin (IVIG) therapy</span><span class="source" tagx="source" title="source">Autoimmun Rev</span><span class="volume" tagx="volume" title="volume">6</span><span class="year" tagx="year" title="year">2007</span><span class="fpage" tagx="fpage" title="fpage">257</span><span class="lpage" tagx="lpage" title="lpage">259</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.autrev.2006.08.011">10.1016/j.autrev.2006.08.011</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17317619">17317619</a></span></span></li> <li tag="ref"><a name="bb0170" /><span class="label" tagx="label" title="label">34</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ahn</span><span class="given-names" tagx="given-names" title="given-names">J.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sohn</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">S.H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cho</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hyun</span><span class="given-names" tagx="given-names" title="given-names">J.H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Baek</span><span class="given-names" tagx="given-names" title="given-names">Y.J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Use of convalescent plasma therapy in two COVID-19 patients with acute respiratory distress syndrome in Korea</span><span class="source" tagx="source" title="source">J Korean Med Sci</span><span class="volume" tagx="volume" title="volume">35</span><span class="year" tagx="year" title="year">2020</span>e149<span class="pub-id"><a href="https://dx.doi.org/10.3346/jkms.2020.35.e149">10.3346/jkms.2020.35.e149</a></span></span></li> <li tag="ref"><a name="bb0175" /><span class="label" tagx="label" title="label">35</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ko</span><span class="given-names" tagx="given-names" title="given-names">J.-H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Seok</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cho</span><span class="given-names" tagx="given-names" title="given-names">S.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ha</span><span class="given-names" tagx="given-names" title="given-names">Y.E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Baek</span><span class="given-names" tagx="given-names" title="given-names">J.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">S.H.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: A single centre experience</span><span class="source" tagx="source" title="source">Antivir Ther</span><span class="volume" tagx="volume" title="volume">23</span><span class="year" tagx="year" title="year">2018</span><span class="fpage" tagx="fpage" title="fpage">617</span><span class="lpage" tagx="lpage" title="lpage">622</span><span class="pub-id"><a href="https://dx.doi.org/10.3851/IMP3243">10.3851/IMP3243</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29923831">29923831</a></span></span></li> <li tag="ref"><a name="bb0180" /><span class="label" tagx="label" title="label">36</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Spalter</span><span class="given-names" tagx="given-names" title="given-names">S.H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kaveri</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kazatchkine</span><span class="given-names" tagx="given-names" title="given-names">M.D.</span></span></span><span class="chapter-title" tagx="chapter-title" title="chapter-title">Anti-idiotypes to autoantibodies in therapeutic preparations of normal polyspecific human IgG (intravenous immunoglobulin, IVIg)</span><span class="comment">editors</span><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shoenfeld</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kennedy</span><span class="given-names" tagx="given-names" title="given-names">R.C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ferrone Infection and Cancer SBT-I in MA</span></span></span><span class="source" tagx="source" title="source">Idiotypes Med. Autoimmun. Infect. Cancer</span><span class="year" tagx="year" title="year">1997</span><span class="publisher-name" tagx="publisher-name" title="publisher-name">Elsevier</span><span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Amsterdam</span><span class="fpage" tagx="fpage" title="fpage">217</span><span class="lpage" tagx="lpage" title="lpage">225</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/B978-044482807-1/50021-1">10.1016/B978-044482807-1/50021-1</a></span></span></li> <li tag="ref"><a name="bb0185" /><span class="label" tagx="label" title="label">37</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ye</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fu</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ren</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Treatment with convalescent plasma for COVID-19 patients in Wuhan, China</span><span class="source" tagx="source" title="source">J Med Virol</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1002/jmv.25882">10.1002/jmv.25882</a></span></span></li> <li tag="ref"><a name="bb0190" /><span class="label" tagx="label" title="label">38</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shen</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yuan</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Treatment of 5 critically ill patients with Covid-19 with convalescent plasma</span><span class="source" tagx="source" title="source">JAMA</span><span class="volume" tagx="volume" title="volume">323</span><span class="issue" tagx="issue" title="issue">16</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">1582</span><span class="lpage" tagx="lpage" title="lpage">1589</span><span class="pub-id"><a href="https://dx.doi.org/10.1001/jama.2020.4783">10.1001/jama.2020.4783</a></span></span></li> <li tag="ref"><a name="bb0195" /><span class="label" tagx="label" title="label">39</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Duan</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Qu</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Effectiveness of convalescent plasma therapy in severe COVID-19 patients</span><span class="source" tagx="source" title="source">Proc Natl Acad Sci U S A</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1073/pnas.2004168117">10.1073/pnas.2004168117</a></span></span></li> <li tag="ref"><a name="bb0200" /><span class="label" tagx="label" title="label">40</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Soo</span><span class="given-names" tagx="given-names" title="given-names">Y.O.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cheng</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wong</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hui</span><span class="given-names" tagx="given-names" title="given-names">D.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">C.K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tsang</span><span class="given-names" tagx="given-names" title="given-names">K.K.S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients</span><span class="source" tagx="source" title="source">Clin Microbiol Infect</span><span class="volume" tagx="volume" title="volume">10</span><span class="year" tagx="year" title="year">2004</span><span class="fpage" tagx="fpage" title="fpage">676</span><span class="lpage" tagx="lpage" title="lpage">678</span><span class="pub-id"><a href="https://dx.doi.org/10.1111/j.1469-0691.2004.00956.x">10.1111/j.1469-0691.2004.00956.x</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15214887">15214887</a></span></span></li> <li tag="ref"><a name="bb0205" /><span class="label" tagx="label" title="label">41</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cheng</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wong</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Soo</span><span class="given-names" tagx="given-names" title="given-names">Y.O.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wong</span><span class="given-names" tagx="given-names" title="given-names">W.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">C.K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ng</span><span class="given-names" tagx="given-names" title="given-names">M.H.L.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Use of convalescent plasma therapy in SARS patients in Hong Kong</span><span class="source" tagx="source" title="source">Eur J Clin Microbiol Infect Dis</span><span class="volume" tagx="volume" title="volume">24</span><span class="year" tagx="year" title="year">2005</span><span class="fpage" tagx="fpage" title="fpage">44</span><span class="lpage" tagx="lpage" title="lpage">46</span><span class="pub-id"><a href="https://dx.doi.org/10.1007/s10096-004-1271-9">10.1007/s10096-004-1271-9</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15616839">15616839</a></span></span></li> <li tag="ref"><a name="bb0210" /><span class="label" tagx="label" title="label">42</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yeh</span><span class="given-names" tagx="given-names" title="given-names">K.-M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chiueh</span><span class="given-names" tagx="given-names" title="given-names">T.-S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Siu</span><span class="given-names" tagx="given-names" title="given-names">L.K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lin</span><span class="given-names" tagx="given-names" title="given-names">J.-C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chan</span><span class="given-names" tagx="given-names" title="given-names">P.K.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Peng</span><span class="given-names" tagx="given-names" title="given-names">M.-Y.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital</span><span class="source" tagx="source" title="source">J Antimicrob Chemother</span><span class="volume" tagx="volume" title="volume">56</span><span class="year" tagx="year" title="year">2005</span><span class="fpage" tagx="fpage" title="fpage">919</span><span class="lpage" tagx="lpage" title="lpage">922</span><span class="pub-id"><a href="https://dx.doi.org/10.1093/jac/dki346">10.1093/jac/dki346</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16183666">16183666</a></span></span></li> <li tag="ref"><a name="bb0215" /><span class="label" tagx="label" title="label">43</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jiang</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nie</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Epidemiologic features, clinical diagnosis and therapy of first cluster of patients with severe acute respiratory syndrome in Beijing area</span><span class="source" tagx="source" title="source">Zhonghua Yi Xue Za Zhi</span><span class="volume" tagx="volume" title="volume">83</span><span class="year" tagx="year" title="year">2003</span><span class="fpage" tagx="fpage" title="fpage">1018</span><span class="lpage" tagx="lpage" title="lpage">1022</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12899773">12899773</a></span></span></li> <li tag="ref"><a name="bb0220" /><span class="label" tagx="label" title="label">44</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kong</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Letter to editor</span><span class="source" tagx="source" title="source">Transfus Apher Sci</span><span class="volume" tagx="volume" title="volume">29</span><span class="year" tagx="year" title="year">2003</span><span class="fpage" tagx="fpage" title="fpage">101</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/S1473-0502(03)00109-5">10.1016/S1473-0502(03)00109-5</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12952008">12952008</a></span></span></li> <li tag="ref"><a name="bb0225" /><span class="label" tagx="label" title="label">45</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wong</span><span class="given-names" tagx="given-names" title="given-names">V.W.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dai</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">A.K.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sung</span><span class="given-names" tagx="given-names" title="given-names">J.J.Y.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Treatment of severe acute respiratory syndrome with convalescent plasma</span><span class="source" tagx="source" title="source">Hong Kong Med J</span><span class="volume" tagx="volume" title="volume">9</span><span class="year" tagx="year" title="year">2003</span><span class="fpage" tagx="fpage" title="fpage">199</span><span class="lpage" tagx="lpage" title="lpage">201</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12777656">12777656</a></span></span></li> <li tag="ref"><a name="bb0230" /><span class="label" tagx="label" title="label">46</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hung</span><span class="given-names" tagx="given-names" title="given-names">I.F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">To KK</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">C.-K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">K.-L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chan</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yan</span><span class="given-names" tagx="given-names" title="given-names">W.-W.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection</span><span class="source" tagx="source" title="source">Clin Infect Dis</span><span class="volume" tagx="volume" title="volume">52</span><span class="year" tagx="year" title="year">2011</span><span class="fpage" tagx="fpage" title="fpage">447</span><span class="lpage" tagx="lpage" title="lpage">456</span><span class="pub-id"><a href="https://dx.doi.org/10.1093/cid/ciq106">10.1093/cid/ciq106</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21248066">21248066</a></span></span></li> <li tag="ref"><a name="bb0235" /><span class="label" tagx="label" title="label">47</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chan</span><span class="given-names" tagx="given-names" title="given-names">K.K.C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">K.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lam</span><span class="given-names" tagx="given-names" title="given-names">P.K.N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Law</span><span class="given-names" tagx="given-names" title="given-names">K.I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Joynt</span><span class="given-names" tagx="given-names" title="given-names">G.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yan</span><span class="given-names" tagx="given-names" title="given-names">W.W.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Hong Kongâ€™s experience on the use of extracorporeal membrane oxygenation for the treatment of influenza A (H1N1)</span><span class="source" tagx="source" title="source">Hong Kong Med J</span><span class="volume" tagx="volume" title="volume">16</span><span class="year" tagx="year" title="year">2010</span><span class="fpage" tagx="fpage" title="fpage">447</span><span class="lpage" tagx="lpage" title="lpage">454</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21135421">21135421</a></span></span></li> <li tag="ref"><a name="bb0240" /><span class="label" tagx="label" title="label">48</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gao</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Feng</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shu</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xiang</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China</span><span class="source" tagx="source" title="source">PLoS One</span><span class="volume" tagx="volume" title="volume">3</span><span class="year" tagx="year" title="year">2008</span>e2985<span class="pub-id"><a href="https://dx.doi.org/10.1371/journal.pone.0002985">10.1371/journal.pone.0002985</a></span></span></li> <li tag="ref"><a name="bb0245" /><span class="label" tagx="label" title="label">49</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kong</span><span class="given-names" tagx="given-names" title="given-names">L.K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">B.P.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Successful treatment of avian influenza with convalescent plasma</span><span class="source" tagx="source" title="source">Hong Kong Med J</span><span class="volume" tagx="volume" title="volume">12</span><span class="year" tagx="year" title="year">2006</span><span class="fpage" tagx="fpage" title="fpage">489</span></span></li> <li tag="ref"><a name="bb0250" /><span class="label" tagx="label" title="label">50</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wong</span><span class="given-names" tagx="given-names" title="given-names">S.S.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yuen</span><span class="given-names" tagx="given-names" title="given-names">K.-Y.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The management of coronavirus infections with particular reference to SARS</span><span class="source" tagx="source" title="source">J Antimicrob Chemother</span><span class="volume" tagx="volume" title="volume">62</span><span class="year" tagx="year" title="year">2008</span><span class="fpage" tagx="fpage" title="fpage">437</span><span class="lpage" tagx="lpage" title="lpage">441</span><span class="pub-id"><a href="https://dx.doi.org/10.1093/jac/dkn243">10.1093/jac/dkn243</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18565970">18565970</a></span></span></li> <li tag="ref"><a name="bb0255" /><span class="label" tagx="label" title="label">51</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zeng</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lin</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liang</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical characteristics and therapeutic experience of case of severe highly pathogenic A/H5N1 avian influenza with bronchopleural fistula</span><span class="source" tagx="source" title="source">Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese J Tuberc Respir Dis</span><span class="volume" tagx="volume" title="volume">32</span><span class="year" tagx="year" title="year">2009</span><span class="fpage" tagx="fpage" title="fpage">356</span><span class="lpage" tagx="lpage" title="lpage">359</span></span></li> <li tag="ref"><a name="bb0260" /><span class="label" tagx="label" title="label">52</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tiberghien</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">de Lambalerie</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Morel</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gallian</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lacombe</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yazdanpanah</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Collecting and evaluating convalescent plasma for COVID-19 treatment: Why and how</span><span class="source" tagx="source" title="source">Vox Sang</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1111/vox.12926">10.1111/vox.12926</a></span></span></li> <li tag="ref"><a name="bb0265" /><span class="label" tagx="label" title="label">53</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tissot</span><span class="given-names" tagx="given-names" title="given-names">J.-D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Garraud</span><span class="given-names" tagx="given-names" title="given-names">O.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Ethics and blood donation: A marriage of convenience</span><span class="source" tagx="source" title="source">Press Medicale</span><span class="volume" tagx="volume" title="volume">45</span><span class="year" tagx="year" title="year">2016</span><span class="fpage" tagx="fpage" title="fpage">e247</span><span class="lpage" tagx="lpage" title="lpage">e252</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.lpm.2016.06.016">10.1016/j.lpm.2016.06.016</a></span></span></li> <li tag="ref"><a name="bb0270" /><span class="label" tagx="label" title="label">54</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bloch</span><span class="given-names" tagx="given-names" title="given-names">E.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shoham</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Casadevall</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sachais</span><span class="given-names" tagx="given-names" title="given-names">B.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shaz</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Winters</span><span class="given-names" tagx="given-names" title="given-names">J.L.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Deployment of convalescent plasma for the prevention and treatment of COVID-19</span><span class="source" tagx="source" title="source">J Clin Invest</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1172/JCI138745">10.1172/JCI138745</a></span></span></li> <li tag="ref"><a name="bb0275" /><span class="label" tagx="label" title="label">55</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dodd</span><span class="given-names" tagx="given-names" title="given-names">R.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Crowder</span><span class="given-names" tagx="given-names" title="given-names">L.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Haynes</span><span class="given-names" tagx="given-names" title="given-names">J.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Notari</span><span class="given-names" tagx="given-names" title="given-names">E.P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stramer</span><span class="given-names" tagx="given-names" title="given-names">S.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Steele</span><span class="given-names" tagx="given-names" title="given-names">W.R.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Screening blood donors for HIV, HCV, and HBV at the American Red Cross: 10-year trends in prevalence, incidence, and residual risk, 2007 to 2016</span><span class="source" tagx="source" title="source">Transfus Med Rev</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.tmrv.2020.02.001">10.1016/j.tmrv.2020.02.001</a></span></span></li> <li tag="ref"><a name="bb0280" /><span class="label" tagx="label" title="label">56</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Niazi</span><span class="given-names" tagx="given-names" title="given-names">S.K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bhatti</span><span class="given-names" tagx="given-names" title="given-names">F.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Salamat</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ghani</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tayyab</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Impact of nucleic acid amplification test on screening of blood donors in Northern Pakistan</span><span class="source" tagx="source" title="source">Transfusion</span><span class="volume" tagx="volume" title="volume">55</span><span class="year" tagx="year" title="year">2015</span><span class="fpage" tagx="fpage" title="fpage">1803</span><span class="lpage" tagx="lpage" title="lpage">1811</span><span class="pub-id"><a href="https://dx.doi.org/10.1111/trf.13017">10.1111/trf.13017</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25648663">25648663</a></span></span></li> <li tag="ref"><a name="bb0285" /><span class="label" tagx="label" title="label">57</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bello-LÃ³pez</span><span class="given-names" tagx="given-names" title="given-names">J.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Delgado-Balbuena</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rojas-Huidobro</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rojo-Medina</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Treatment of platelet concentrates and plasma with riboflavin and UV light: Impact in bacterial reduction</span><span class="source" tagx="source" title="source">Transfus Clin Biol</span><span class="volume" tagx="volume" title="volume">25</span><span class="year" tagx="year" title="year">2018</span><span class="fpage" tagx="fpage" title="fpage">197</span><span class="lpage" tagx="lpage" title="lpage">203</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.tracli.2018.03.004">10.1016/j.tracli.2018.03.004</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29656962">29656962</a></span></span></li> <li tag="ref"><a name="bb0290" /><span class="label" tagx="label" title="label">58</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Benjamin</span><span class="given-names" tagx="given-names" title="given-names">R.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">McLaughlin</span><span class="given-names" tagx="given-names" title="given-names">L.S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Plasma components: Properties, differences, and uses</span><span class="source" tagx="source" title="source">Transfusion</span><span class="volume" tagx="volume" title="volume">52</span><span class="issue" tagx="issue" title="issue">Suppl. 1</span><span class="year" tagx="year" title="year">2012</span><span class="fpage" tagx="fpage" title="fpage">9S</span><span class="lpage" tagx="lpage" title="lpage">19S</span><span class="pub-id"><a href="https://dx.doi.org/10.1111/j.1537-2995.2012.03622.x">10.1111/j.1537-2995.2012.03622.x</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22578375">22578375</a></span></span></li> <li tag="ref"><a name="bb0295" /><span class="label" tagx="label" title="label">59</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Du</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">He</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zheng</span><span class="given-names" tagx="given-names" title="given-names">B.-J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jiang</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The spike protein of SARS-CoV--a target for vaccine and therapeutic development</span><span class="source" tagx="source" title="source">Nat Rev Microbiol</span><span class="volume" tagx="volume" title="volume">7</span><span class="year" tagx="year" title="year">2009</span><span class="fpage" tagx="fpage" title="fpage">226</span><span class="lpage" tagx="lpage" title="lpage">236</span><span class="pub-id"><a href="https://dx.doi.org/10.1038/nrmicro2090">10.1038/nrmicro2090</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19198616">19198616</a></span></span></li> <li tag="ref"><a name="bb0300" /><span class="label" tagx="label" title="label">60</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tian</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xia</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lu</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shi</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody</span><span class="source" tagx="source" title="source">Emerg Microbes Infect</span><span class="volume" tagx="volume" title="volume">9</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">382</span><span class="lpage" tagx="lpage" title="lpage">385</span><span class="pub-id"><a href="https://dx.doi.org/10.1080/22221751.2020.1729069">10.1080/22221751.2020.1729069</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32065055">32065055</a></span></span></li> <li tag="ref"><a name="bb0305" /><span class="label" tagx="label" title="label">61</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Q.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xia</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications</span><span class="source" tagx="source" title="source">MedRxiv</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1101/2020.03.30.20047365">10.1101/2020.03.30.20047365</a></span></span></li> <li tag="ref"><a name="bb0310" /><span class="label" tagx="label" title="label">62</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hsueh</span><span class="given-names" tagx="given-names" title="given-names">P.-R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">L.-M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">P.-J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kao</span><span class="given-names" tagx="given-names" title="given-names">C.-L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">P.-C.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus</span><span class="source" tagx="source" title="source">Clin Microbiol Infect</span><span class="volume" tagx="volume" title="volume">10</span><span class="year" tagx="year" title="year">2004</span><span class="fpage" tagx="fpage" title="fpage">1062</span><span class="lpage" tagx="lpage" title="lpage">1066</span><span class="pub-id"><a href="https://dx.doi.org/10.1111/j.1469-0691.2004.01009.x">10.1111/j.1469-0691.2004.01009.x</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15606632">15606632</a></span></span></li> <li tag="ref"><a name="bb0315" /><span class="label" tagx="label" title="label">63</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gorse</span><span class="given-names" tagx="given-names" title="given-names">G.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Donovan</span><span class="given-names" tagx="given-names" title="given-names">M.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Patel</span><span class="given-names" tagx="given-names" title="given-names">G.B.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus-associated illnesses</span><span class="source" tagx="source" title="source">J Med Virol</span><span class="volume" tagx="volume" title="volume">92</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">512</span><span class="lpage" tagx="lpage" title="lpage">517</span><span class="pub-id"><a href="https://dx.doi.org/10.1002/jmv.25715">10.1002/jmv.25715</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32073157">32073157</a></span></span></li> <li tag="ref"><a name="bb0320" /><span class="label" tagx="label" title="label">64</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rokni</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ghasemi</span><span class="given-names" tagx="given-names" title="given-names">V.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tavakoli</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS</span><span class="source" tagx="source" title="source">Rev Med Virol</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1002/rmv.2107">10.1002/rmv.2107</a></span></span></li> <li tag="ref"><a name="bb0325" /><span class="label" tagx="label" title="label">65</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chaigne</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mouthon</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Mechanisms of action of intravenous immunoglobulin</span><span class="source" tagx="source" title="source">Transfus Apher Sci</span><span class="volume" tagx="volume" title="volume">56</span><span class="year" tagx="year" title="year">2017</span><span class="fpage" tagx="fpage" title="fpage">45</span><span class="lpage" tagx="lpage" title="lpage">49</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.transci.2016.12.017">10.1016/j.transci.2016.12.017</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28161150">28161150</a></span></span></li> <li tag="ref"><a name="bb0330" /><span class="label" tagx="label" title="label">66</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xiao</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xia</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cao</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jiang</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Coagulopathy and antiphospholipid antibodies in patients with Covid-19</span><span class="source" tagx="source" title="source">N Engl J Med</span><span class="volume" tagx="volume" title="volume">382</span><span class="issue" tagx="issue" title="issue">17</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">e38</span><span class="pub-id"><a href="https://dx.doi.org/10.1056/NEJMc2007575">10.1056/NEJMc2007575</a></span><span class="comment">In press</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32268022">32268022</a></span></span></li> <li tag="ref"><a name="bb0335" /><span class="label" tagx="label" title="label">67</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lutz</span><span class="given-names" tagx="given-names" title="given-names">H.U.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">SpÃ¤th</span><span class="given-names" tagx="given-names" title="given-names">P.J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Anti-inflammatory effect of intravenous immunoglobulin mediated through modulation of complement activation</span><span class="source" tagx="source" title="source">Clin Rev Allergy Immunol</span><span class="volume" tagx="volume" title="volume">29</span><span class="year" tagx="year" title="year">2005</span><span class="fpage" tagx="fpage" title="fpage">207</span><span class="lpage" tagx="lpage" title="lpage">212</span><span class="pub-id"><a href="https://dx.doi.org/10.1385/CRIAI:29:3:207">10.1385/CRIAI:29:3:207</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16391395">16391395</a></span></span></li> <li tag="ref"><a name="bb0340" /><span class="label" tagx="label" title="label">68</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Basta</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Van Goor</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Luccioli</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Billings</span><span class="given-names" tagx="given-names" title="given-names">E.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vortmeyer</span><span class="given-names" tagx="given-names" title="given-names">A.O.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Baranyi</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span></span><span class="mixed-article-title" title="mixed-article-title">F(ab)â€™2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins</span><span class="source" tagx="source" title="source">Nat Med</span><span class="volume" tagx="volume" title="volume">9</span><span class="year" tagx="year" title="year">2003</span><span class="fpage" tagx="fpage" title="fpage">431</span><span class="lpage" tagx="lpage" title="lpage">438</span><span class="pub-id"><a href="https://dx.doi.org/10.1038/nm836">10.1038/nm836</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12612546">12612546</a></span></span></li> <li tag="ref"><a name="bb0345" /><span class="label" tagx="label" title="label">69</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gralinski</span><span class="given-names" tagx="given-names" title="given-names">L.E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sheahan</span><span class="given-names" tagx="given-names" title="given-names">T.P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Morrison</span><span class="given-names" tagx="given-names" title="given-names">T.E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Menachery</span><span class="given-names" tagx="given-names" title="given-names">V.D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jensen</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Leist</span><span class="given-names" tagx="given-names" title="given-names">S.R.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis</span><span class="source" tagx="source" title="source">MBio</span><span class="volume" tagx="volume" title="volume">9</span><span class="year" tagx="year" title="year">2018</span><span class="pub-id"><a href="https://dx.doi.org/10.1128/mBio.01753-18">10.1128/mBio.01753-18</a></span></span></li> <li tag="ref"><a name="bb0350" /><span class="label" tagx="label" title="label">70</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Abe</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Horiuchi</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Miyake</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kimura</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Anti-cytokine nature of natural human immunoglobulin: one possible mechanism of the clinical effect of intravenous immunoglobulin therapy</span><span class="source" tagx="source" title="source">Immunol Rev</span><span class="volume" tagx="volume" title="volume">139</span><span class="year" tagx="year" title="year">1994</span><span class="fpage" tagx="fpage" title="fpage">5</span><span class="lpage" tagx="lpage" title="lpage">19</span><span class="pub-id"><a href="https://dx.doi.org/10.1111/j.1600-065x.1994.tb00854.x">10.1111/j.1600-065x.1994.tb00854.x</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/7927413">7927413</a></span></span></li> <li tag="ref"><a name="bb0355" /><span class="label" tagx="label" title="label">71</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kulkarni</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span></span><span class="chapter-title" tagx="chapter-title" title="chapter-title">Antibody-dependent enhancement of viral infections BT - Dynamics of immune activation in viral diseases</span><span class="comment">editor</span><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bramhachari</span><span class="given-names" tagx="given-names" title="given-names">P.V.</span></span></span><span class="source" tagx="source" title="source">Dyn. Immune Act. Viral Dis</span><span class="year" tagx="year" title="year">2020</span><span class="publisher-name" tagx="publisher-name" title="publisher-name">Springer Singapore</span><span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Singapore</span><span class="fpage" tagx="fpage" title="fpage">9</span><span class="lpage" tagx="lpage" title="lpage">41</span><span class="pub-id"><a href="https://dx.doi.org/10.1007/978-981-15-1045-8_2">10.1007/978-981-15-1045-8_2</a></span></span></li> <li tag="ref"><a name="bb0360" /><span class="label" tagx="label" title="label">72</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vatti</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Monsalve</span><span class="given-names" tagx="given-names" title="given-names">D.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pacheco</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chang</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Anaya</span><span class="given-names" tagx="given-names" title="given-names">J.-M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gershwin</span><span class="given-names" tagx="given-names" title="given-names">M.E.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Original antigenic sin: A comprehensive review</span><span class="source" tagx="source" title="source">J Autoimmun</span><span class="volume" tagx="volume" title="volume">83</span><span class="year" tagx="year" title="year">2017</span><span class="fpage" tagx="fpage" title="fpage">12</span><span class="lpage" tagx="lpage" title="lpage">21</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.jaut.2017.04.008">10.1016/j.jaut.2017.04.008</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28479213">28479213</a></span></span></li> <li tag="ref"><a name="bb0365" /><span class="label" tagx="label" title="label">73</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">S.-F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tseng</span><span class="given-names" tagx="given-names" title="given-names">S.-P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yen</span><span class="given-names" tagx="given-names" title="given-names">C.-H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">J.-Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tsao</span><span class="given-names" tagx="given-names" title="given-names">C.-H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shen</span><span class="given-names" tagx="given-names" title="given-names">C.-W.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins</span><span class="source" tagx="source" title="source">Biochem Biophys Res Commun</span><span class="volume" tagx="volume" title="volume">451</span><span class="year" tagx="year" title="year">2014</span><span class="fpage" tagx="fpage" title="fpage">208</span><span class="lpage" tagx="lpage" title="lpage">214</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.bbrc.2014.07.090">10.1016/j.bbrc.2014.07.090</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25073113">25073113</a></span></span></li> <li tag="ref"><a name="bb0370" /><span class="label" tagx="label" title="label">74</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Casadevall</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pirofski</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The convalescent sera option for containing COVID-19</span><span class="source" tagx="source" title="source">J Clin Invest</span><span class="volume" tagx="volume" title="volume">130</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">1545</span><span class="lpage" tagx="lpage" title="lpage">1548</span><span class="pub-id"><a href="https://dx.doi.org/10.1172/JCI138003">10.1172/JCI138003</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32167489">32167489</a></span></span></li> <li tag="ref"><a name="bb0375" /><span class="label" tagx="label" title="label">75</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nimmerjahn</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ravetch</span><span class="given-names" tagx="given-names" title="given-names">J.V.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Anti-inflammatory actions of intravenous immunoglobulin</span><span class="source" tagx="source" title="source">Annu Rev Immunol</span><span class="volume" tagx="volume" title="volume">26</span><span class="year" tagx="year" title="year">2008</span><span class="fpage" tagx="fpage" title="fpage">513</span><span class="lpage" tagx="lpage" title="lpage">533</span><span class="pub-id"><a href="https://dx.doi.org/10.1146/annurev.immunol.26.021607.090232">10.1146/annurev.immunol.26.021607.090232</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18370923">18370923</a></span></span></li> <li tag="ref"><a name="bb0380" /><span class="label" tagx="label" title="label">76</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kiessling</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lledo-Garcia</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Watanabe</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Langdon</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tran</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bari</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study</span><span class="source" tagx="source" title="source">Sci Transl Med</span><span class="volume" tagx="volume" title="volume">9</span><span class="year" tagx="year" title="year">2017</span><span class="pub-id"><a href="https://dx.doi.org/10.1126/scitranslmed.aan1208">10.1126/scitranslmed.aan1208</a></span></span></li> <li tag="ref"><a name="bb0385" /><span class="label" tagx="label" title="label">77</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Litzman</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Influence of FCRN expression on lung decline and intravenous immunoglobulin catabolism in common variable immunodeficiency patients</span><span class="source" tagx="source" title="source">Clin Exp Immunol</span><span class="volume" tagx="volume" title="volume">178</span><span class="issue" tagx="issue" title="issue">Suppl</span><span class="year" tagx="year" title="year">2014</span><span class="fpage" tagx="fpage" title="fpage">103</span><span class="lpage" tagx="lpage" title="lpage">104</span><span class="pub-id"><a href="https://dx.doi.org/10.1111/cei.12529">10.1111/cei.12529</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25546780">25546780</a></span></span></li> <li tag="ref"><a name="bb0390" /><span class="label" tagx="label" title="label">78</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Akilesh</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Petkova</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sproule</span><span class="given-names" tagx="given-names" title="given-names">T.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shaffer</span><span class="given-names" tagx="given-names" title="given-names">D.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Christianson</span><span class="given-names" tagx="given-names" title="given-names">G.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Roopenian</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease</span><span class="source" tagx="source" title="source">J Clin Invest</span><span class="volume" tagx="volume" title="volume">113</span><span class="year" tagx="year" title="year">2004</span><span class="fpage" tagx="fpage" title="fpage">1328</span><span class="lpage" tagx="lpage" title="lpage">1333</span><span class="pub-id"><a href="https://dx.doi.org/10.1172/JCI18838">10.1172/JCI18838</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15124024">15124024</a></span></span></li> <li tag="ref"><a name="bb0395" /><span class="label" tagx="label" title="label">79</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hansen</span><span class="given-names" tagx="given-names" title="given-names">R.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Balthasar</span><span class="given-names" tagx="given-names" title="given-names">J.P.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia</span><span class="source" tagx="source" title="source">Blood</span><span class="volume" tagx="volume" title="volume">100</span><span class="year" tagx="year" title="year">2002</span><span class="fpage" tagx="fpage" title="fpage">2087</span><span class="lpage" tagx="lpage" title="lpage">2093</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12200371">12200371</a></span></span></li> <li tag="ref"><a name="bb0400" /><span class="label" tagx="label" title="label">80</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hansen</span><span class="given-names" tagx="given-names" title="given-names">R.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Balthasar</span><span class="given-names" tagx="given-names" title="given-names">J.P.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Intravenous immunoglobulin mediates an increase in anti-platelet antibody clearance via the FcRn receptor</span><span class="source" tagx="source" title="source">Thromb Haemost</span><span class="volume" tagx="volume" title="volume">88</span><span class="year" tagx="year" title="year">2002</span><span class="fpage" tagx="fpage" title="fpage">898</span><span class="lpage" tagx="lpage" title="lpage">899</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12529736">12529736</a></span></span></li> <li tag="ref"><a name="bb0405" /><span class="label" tagx="label" title="label">81</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jin</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gong</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lin</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">He</span><span class="given-names" tagx="given-names" title="given-names">Q.</span></span></span><span class="mixed-article-title" title="mixed-article-title">FcÎ³RIIb expression on B cells is associated with treatment efficacy for acute rejection after kidney transplantation</span><span class="source" tagx="source" title="source">Mol Immunol</span><span class="volume" tagx="volume" title="volume">85</span><span class="year" tagx="year" title="year">2017</span><span class="fpage" tagx="fpage" title="fpage">283</span><span class="lpage" tagx="lpage" title="lpage">292</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.molimm.2017.03.006">10.1016/j.molimm.2017.03.006</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28360016">28360016</a></span></span></li> <li tag="ref"><a name="bb0410" /><span class="label" tagx="label" title="label">82</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shrestha</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wiener</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shendre</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kaslow</span><span class="given-names" tagx="given-names" title="given-names">R.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Olson</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Role of activating FcÎ³R gene polymorphisms in Kawasaki disease susceptibility and intravenous immunoglobulin response</span><span class="source" tagx="source" title="source">Circ Cardiovasc Genet</span><span class="volume" tagx="volume" title="volume">5</span><span class="year" tagx="year" title="year">2012</span><span class="fpage" tagx="fpage" title="fpage">309</span><span class="lpage" tagx="lpage" title="lpage">316</span><span class="pub-id"><a href="https://dx.doi.org/10.1161/CIRCGENETICS.111.962464">10.1161/CIRCGENETICS.111.962464</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22565545">22565545</a></span></span></li> <li tag="ref"><a name="bb0415" /><span class="label" tagx="label" title="label">83</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kaneko</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nimmerjahn</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ravetch</span><span class="given-names" tagx="given-names" title="given-names">J.V.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation</span><span class="source" tagx="source" title="source">Science</span><span class="volume" tagx="volume" title="volume">313</span><span class="issue" tagx="issue" title="issue">80</span><span class="year" tagx="year" title="year">2006</span><span class="fpage" tagx="fpage" title="fpage">670</span><span class="lpage" tagx="lpage" title="lpage">673</span><span class="pub-id"><a href="https://dx.doi.org/10.1126/science.1129594">10.1126/science.1129594</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16888140">16888140</a></span></span></li> <li tag="ref"><a name="bb0420" /><span class="label" tagx="label" title="label">84</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Othy</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Topcu</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Saha</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kothapalli</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lacroix-Desmazes</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kasermann</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Sialylation may be dispensable for reciprocal modulation of helper T cells by intravenous immunoglobulin</span><span class="source" tagx="source" title="source">Eur J Immunol</span><span class="volume" tagx="volume" title="volume">44</span><span class="year" tagx="year" title="year">2014</span><span class="fpage" tagx="fpage" title="fpage">2059</span><span class="lpage" tagx="lpage" title="lpage">2063</span><span class="pub-id"><a href="https://dx.doi.org/10.1002/eji.201444440">10.1002/eji.201444440</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24700174">24700174</a></span></span></li> <li tag="ref"><a name="bb0425" /><span class="label" tagx="label" title="label">85</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bayry</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lacroix-Desmazes</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Carbonneil</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Misra</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Donkova</span><span class="given-names" tagx="given-names" title="given-names">V.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pashov</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin</span><span class="source" tagx="source" title="source">Blood</span><span class="volume" tagx="volume" title="volume">101</span><span class="year" tagx="year" title="year">2003</span><span class="fpage" tagx="fpage" title="fpage">758</span><span class="lpage" tagx="lpage" title="lpage">765</span><span class="pub-id"><a href="https://dx.doi.org/10.1182/blood-2002-05-1447">10.1182/blood-2002-05-1447</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12393386">12393386</a></span></span></li> <li tag="ref"><a name="bb0430" /><span class="label" tagx="label" title="label">86</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sharma</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Schoindre</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hegde</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Saha</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Maddur</span><span class="given-names" tagx="given-names" title="given-names">M.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stephen-Victor</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Intravenous immunoglobulin-induced IL-33 is insufficient to mediate basophil expansion in autoimmune patients</span><span class="source" tagx="source" title="source">Sci Rep</span><span class="volume" tagx="volume" title="volume">4</span><span class="year" tagx="year" title="year">2014</span><span class="fpage" tagx="fpage" title="fpage">5672</span><span class="pub-id"><a href="https://dx.doi.org/10.1038/srep05672">10.1038/srep05672</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25012067">25012067</a></span></span></li> <li tag="ref"><a name="bb0435" /><span class="label" tagx="label" title="label">87</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tjon</span><span class="given-names" tagx="given-names" title="given-names">A.S.W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">van Gent</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jaadar</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Martin van Hagen</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mancham</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">van der Laan</span><span class="given-names" tagx="given-names" title="given-names">L.J.W.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Intravenous immunoglobulin treatment in humans suppresses dendritic cell function via stimulation of IL-4 and IL-13 production</span><span class="source" tagx="source" title="source">J Immunol</span><span class="volume" tagx="volume" title="volume">192</span><span class="year" tagx="year" title="year">2014</span><span class="fpage" tagx="fpage" title="fpage">5625</span><span class="lpage" tagx="lpage" title="lpage">5634</span><span class="pub-id"><a href="https://dx.doi.org/10.4049/jimmunol.1301260">10.4049/jimmunol.1301260</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24808368">24808368</a></span></span></li> <li tag="ref"><a name="bb0440" /><span class="label" tagx="label" title="label">88</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Karnam</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rambabu</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Das</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bou-Jaoudeh</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Delignat</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">KÃ¤sermann</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Therapeutic normal IgG intravenous immunoglobulin activates Wnt-Î²-catenin pathway in dendritic cells</span><span class="source" tagx="source" title="source">Commun Biol</span><span class="volume" tagx="volume" title="volume">3</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">96</span><span class="pub-id"><a href="https://dx.doi.org/10.1038/s42003-020-0825-4">10.1038/s42003-020-0825-4</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32132640">32132640</a></span></span></li> <li tag="ref"><a name="bb0445" /><span class="label" tagx="label" title="label">89</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bayry</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lacroix-Desmazes</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Delignat</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mouthon</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Weill</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kazatchkine</span><span class="given-names" tagx="given-names" title="given-names">M.D.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Intravenous immunoglobulin abrogates dendritic cell differentiation induced by interferon-alpha present in serum from patients with systemic lupus erythematosus</span><span class="source" tagx="source" title="source">Arthritis Rheum</span><span class="volume" tagx="volume" title="volume">48</span><span class="year" tagx="year" title="year">2003</span><span class="fpage" tagx="fpage" title="fpage">3497</span><span class="lpage" tagx="lpage" title="lpage">3502</span><span class="pub-id"><a href="https://dx.doi.org/10.1002/art.11346">10.1002/art.11346</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14674000">14674000</a></span></span></li> <li tag="ref"><a name="bb0450" /><span class="label" tagx="label" title="label">90</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sharma</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Saha</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Schoindre</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gilardin</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Benveniste</span><span class="given-names" tagx="given-names" title="given-names">O.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kaveri</span><span class="given-names" tagx="given-names" title="given-names">S.V.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Interferon-Î± inhibition by intravenous immunoglobulin is independent of modulation of the plasmacytoid dendritic cell population in the circulation: Comment on the article by Wiedeman et al</span><span class="source" tagx="source" title="source">Arthritis Rheumatol</span><span class="volume" tagx="volume" title="volume">66</span><span class="year" tagx="year" title="year">2014</span><span class="fpage" tagx="fpage" title="fpage">2308</span><span class="lpage" tagx="lpage" title="lpage">2309</span><span class="pub-id"><a href="https://dx.doi.org/10.1002/art.38683">10.1002/art.38683</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24782250">24782250</a></span></span></li> <li tag="ref"><a name="bb0455" /><span class="label" tagx="label" title="label">91</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Aubin</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lemieux</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bazin</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Indirect inhibition of in vivo and in vitro T-cell responses by intravenous immunoglobulins due to impaired antigen presentation</span><span class="source" tagx="source" title="source">Blood</span><span class="volume" tagx="volume" title="volume">115</span><span class="year" tagx="year" title="year">2010</span><span class="fpage" tagx="fpage" title="fpage">1727</span><span class="lpage" tagx="lpage" title="lpage">1734</span><span class="pub-id"><a href="https://dx.doi.org/10.1182/blood-2009-06-225417">10.1182/blood-2009-06-225417</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19965673">19965673</a></span></span></li> <li tag="ref"><a name="bb0460" /><span class="label" tagx="label" title="label">92</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Issekutz</span><span class="given-names" tagx="given-names" title="given-names">A.C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rowter</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Miescher</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">KÃ¤sermann</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Intravenous IgG (IVIG) and subcutaneous IgG (SCIG) preparations have comparable inhibitory effect on T cell activation, which is not dependent on IgG sialylation, monocytes or B cells</span><span class="source" tagx="source" title="source">Clin Immunol</span><span class="volume" tagx="volume" title="volume">160</span><span class="year" tagx="year" title="year">2015</span><span class="fpage" tagx="fpage" title="fpage">123</span><span class="lpage" tagx="lpage" title="lpage">132</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.clim.2015.05.003">10.1016/j.clim.2015.05.003</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25982320">25982320</a></span></span></li> <li tag="ref"><a name="bb0465" /><span class="label" tagx="label" title="label">93</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ahmadi</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Abdolmohammadi-Vahid</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ghaebi</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Aghebati-Maleki</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Afkham</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Danaii</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Effect of intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss (RPL)</span><span class="source" tagx="source" title="source">Biomed Pharmacother</span><span class="volume" tagx="volume" title="volume">92</span><span class="year" tagx="year" title="year">2017</span><span class="fpage" tagx="fpage" title="fpage">1095</span><span class="lpage" tagx="lpage" title="lpage">1102</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.biopha.2017.06.001">10.1016/j.biopha.2017.06.001</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28622710">28622710</a></span></span></li> <li tag="ref"><a name="bb0470" /><span class="label" tagx="label" title="label">94</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hung</span><span class="given-names" tagx="given-names" title="given-names">I.F.N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">KKW</span><span class="given-names" tagx="given-names" title="given-names">To</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">C.-K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">K.-L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yan</span><span class="given-names" tagx="given-names" title="given-names">W.-W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chan</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection</span><span class="source" tagx="source" title="source">Chest</span><span class="volume" tagx="volume" title="volume">144</span><span class="year" tagx="year" title="year">2013</span><span class="fpage" tagx="fpage" title="fpage">464</span><span class="lpage" tagx="lpage" title="lpage">473</span><span class="pub-id"><a href="https://dx.doi.org/10.1378/chest.12-2907">10.1378/chest.12-2907</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23450336">23450336</a></span></span></li> <li tag="ref"><a name="bb0475" /><span class="label" tagx="label" title="label">95</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Klehmet</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Goehler</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ulm</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kohler</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Meisel</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Meisel</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Effective treatment with intravenous immunoglobulins reduces autoreactive T-cell response in patients with CIDP</span><span class="source" tagx="source" title="source">J Neurol Neurosurg Psychiatry</span><span class="volume" tagx="volume" title="volume">86</span><span class="year" tagx="year" title="year">2015</span><span class="fpage" tagx="fpage" title="fpage">686</span><span class="lpage" tagx="lpage" title="lpage">691</span><span class="pub-id"><a href="https://dx.doi.org/10.1136/jnnp-2014-307708">10.1136/jnnp-2014-307708</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25074566">25074566</a></span></span></li> <li tag="ref"><a name="bb0480" /><span class="label" tagx="label" title="label">96</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">TrÃ©panier</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chabot</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bazin</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Intravenous immunoglobulin modulates the expansion and cytotoxicity of CD8+ T cells</span><span class="source" tagx="source" title="source">Immunology</span><span class="volume" tagx="volume" title="volume">141</span><span class="year" tagx="year" title="year">2014</span><span class="fpage" tagx="fpage" title="fpage">233</span><span class="lpage" tagx="lpage" title="lpage">241</span><span class="pub-id"><a href="https://dx.doi.org/10.1111/imm.12189">10.1111/imm.12189</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24128001">24128001</a></span></span></li> <li tag="ref"><a name="bb0485" /><span class="label" tagx="label" title="label">97</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ye</span><span class="given-names" tagx="given-names" title="given-names">Q.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gong</span><span class="given-names" tagx="given-names" title="given-names">F.-Q.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shang</span><span class="given-names" tagx="given-names" title="given-names">S.-Q.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease</span><span class="source" tagx="source" title="source">Clin Immunol</span><span class="volume" tagx="volume" title="volume">171</span><span class="year" tagx="year" title="year">2016</span><span class="fpage" tagx="fpage" title="fpage">25</span><span class="lpage" tagx="lpage" title="lpage">31</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.clim.2016.08.012">10.1016/j.clim.2016.08.012</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27519954">27519954</a></span></span></li> <li tag="ref"><a name="bb0490" /><span class="label" tagx="label" title="label">98</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Maddur</span><span class="given-names" tagx="given-names" title="given-names">M.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vani</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hegde</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lacroix-Desmazes</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kaveri</span><span class="given-names" tagx="given-names" title="given-names">S.V.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bayry</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin</span><span class="source" tagx="source" title="source">J Allergy Clin Immunol</span><span class="volume" tagx="volume" title="volume">127</span><span class="year" tagx="year" title="year">2011</span><span class="fpage" tagx="fpage" title="fpage">823</span><span class="lpage" tagx="lpage" title="lpage">827</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.jaci.2010.12.1102">10.1016/j.jaci.2010.12.1102</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21281961">21281961</a></span></span></li> <li tag="ref"><a name="bb0495" /><span class="label" tagx="label" title="label">99</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Maddur</span><span class="given-names" tagx="given-names" title="given-names">M.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kaveri</span><span class="given-names" tagx="given-names" title="given-names">S.V.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bayry</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Comparison of different IVIg preparations on IL-17 production by human Th17 cells</span><span class="source" tagx="source" title="source">Autoimmun Rev</span><span class="volume" tagx="volume" title="volume">10</span><span class="year" tagx="year" title="year">2011</span><span class="fpage" tagx="fpage" title="fpage">809</span><span class="lpage" tagx="lpage" title="lpage">810</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.autrev.2011.02.007">10.1016/j.autrev.2011.02.007</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21376142">21376142</a></span></span></li> <li tag="ref"><a name="bb0500" /><span class="label" tagx="label" title="label">100</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">D.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">S.K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">J.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Na</span><span class="given-names" tagx="given-names" title="given-names">B.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hur</span><span class="given-names" tagx="given-names" title="given-names">S.E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Intravenous immunoglobulin G modulates peripheral blood Th17 and Foxp3(+) regulatory T cells in pregnant women with recurrent pregnancy loss</span><span class="source" tagx="source" title="source">Am J Reprod Immunol</span><span class="volume" tagx="volume" title="volume">71</span><span class="year" tagx="year" title="year">2014</span><span class="fpage" tagx="fpage" title="fpage">441</span><span class="lpage" tagx="lpage" title="lpage">450</span><span class="pub-id"><a href="https://dx.doi.org/10.1111/aji.12208">10.1111/aji.12208</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24645850">24645850</a></span></span></li> <li tag="ref"><a name="bb0505" /><span class="label" tagx="label" title="label">101</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tackenberg</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jelcic</span><span class="given-names" tagx="given-names" title="given-names">I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Baerenwaldt</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Oertel</span><span class="given-names" tagx="given-names" title="given-names">W.H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sommer</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nimmerjahn</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Impaired inhibitory Fc gamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy</span><span class="source" tagx="source" title="source">Proc Natl Acad Sci U S A</span><span class="volume" tagx="volume" title="volume">106</span><span class="year" tagx="year" title="year">2009</span><span class="fpage" tagx="fpage" title="fpage">4788</span><span class="lpage" tagx="lpage" title="lpage">4792</span><span class="pub-id"><a href="https://dx.doi.org/10.1073/pnas.0807319106">10.1073/pnas.0807319106</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19261857">19261857</a></span></span></li> <li tag="ref"><a name="bb0510" /><span class="label" tagx="label" title="label">102</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nikolova</span><span class="given-names" tagx="given-names" title="given-names">K.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tchorbanov</span><span class="given-names" tagx="given-names" title="given-names">A.I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Djoumerska-Alexieva</span><span class="given-names" tagx="given-names" title="given-names">I.K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nikolova</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vassilev</span><span class="given-names" tagx="given-names" title="given-names">T.L.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Intravenous immunoglobulin up-regulates the expression of the inhibitory Fc gamma IIB receptor on B cells</span><span class="source" tagx="source" title="source">Immunol Cell Biol</span><span class="volume" tagx="volume" title="volume">87</span><span class="year" tagx="year" title="year">2009</span><span class="fpage" tagx="fpage" title="fpage">529</span><span class="lpage" tagx="lpage" title="lpage">533</span><span class="pub-id"><a href="https://dx.doi.org/10.1038/icb.2009.36">10.1038/icb.2009.36</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19488062">19488062</a></span></span></li> <li tag="ref"><a name="bb0515" /><span class="label" tagx="label" title="label">103</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">SÃ©itÃ©</span><span class="given-names" tagx="given-names" title="given-names">J.-F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guerrier</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cornec</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jamin</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Youinou</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hillion</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">TLR9 responses of B cells are repressed by intravenous immunoglobulin through the recruitment of phosphatase</span><span class="source" tagx="source" title="source">J Autoimmun</span><span class="volume" tagx="volume" title="volume">37</span><span class="year" tagx="year" title="year">2011</span><span class="fpage" tagx="fpage" title="fpage">190</span><span class="lpage" tagx="lpage" title="lpage">197</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.jaut.2011.05.014">10.1016/j.jaut.2011.05.014</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21689906">21689906</a></span></span></li> <li tag="ref"><a name="bb0520" /><span class="label" tagx="label" title="label">104</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Le Pottier</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bendaoud</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dueymes</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Daridon</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Youinou</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shoenfeld</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span></span><span class="mixed-article-title" title="mixed-article-title">BAFF, a new target for intravenous immunoglobulin in autoimmunity and cancer</span><span class="source" tagx="source" title="source">J Clin Immunol</span><span class="volume" tagx="volume" title="volume">27</span><span class="year" tagx="year" title="year">2007</span><span class="fpage" tagx="fpage" title="fpage">257</span><span class="lpage" tagx="lpage" title="lpage">265</span><span class="pub-id"><a href="https://dx.doi.org/10.1007/s10875-007-9082-2">10.1007/s10875-007-9082-2</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17393290">17393290</a></span></span></li> <li tag="ref"><a name="bb0525" /><span class="label" tagx="label" title="label">105</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Prasad</span><span class="given-names" tagx="given-names" title="given-names">N.K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Papoff</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zeuner</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bonnin</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kazatchkine</span><span class="given-names" tagx="given-names" title="given-names">M.D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ruberti</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway</span><span class="source" tagx="source" title="source">J Immunol</span><span class="volume" tagx="volume" title="volume">161</span><span class="year" tagx="year" title="year">1998</span><span class="fpage" tagx="fpage" title="fpage">3781</span><span class="lpage" tagx="lpage" title="lpage">3790</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9759905">9759905</a></span></span></li> <li tag="ref"><a name="bb0530" /><span class="label" tagx="label" title="label">106</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Paquin Proulx</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Aubin</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lemieux</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bazin</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Inhibition of B cell-mediated antigen presentation by intravenous immunoglobulins (IVIg)</span><span class="source" tagx="source" title="source">Clin Immunol</span><span class="volume" tagx="volume" title="volume">135</span><span class="year" tagx="year" title="year">2010</span><span class="fpage" tagx="fpage" title="fpage">422</span><span class="lpage" tagx="lpage" title="lpage">429</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.clim.2010.01.001">10.1016/j.clim.2010.01.001</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20138586">20138586</a></span></span></li> <li tag="ref"><a name="bb0535" /><span class="label" tagx="label" title="label">107</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">SÃ©Ã¯tÃ©</span><span class="given-names" tagx="given-names" title="given-names">J.-F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cornec</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Renaudineau</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Youinou</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mageed</span><span class="given-names" tagx="given-names" title="given-names">R.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hillion</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes</span><span class="source" tagx="source" title="source">Blood</span><span class="volume" tagx="volume" title="volume">116</span><span class="year" tagx="year" title="year">2010</span><span class="fpage" tagx="fpage" title="fpage">1698</span><span class="lpage" tagx="lpage" title="lpage">1704</span><span class="pub-id"><a href="https://dx.doi.org/10.1182/blood-2009-12-261461">10.1182/blood-2009-12-261461</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/20516366">20516366</a></span></span></li> <li tag="ref"><a name="bb0540" /><span class="label" tagx="label" title="label">108</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Blanco-Melo</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nilsson-Payant</span><span class="given-names" tagx="given-names" title="given-names">B.E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chun Liu</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Uhl</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hoagland</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">MÃ¸ller</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Imbalanced host response to SARS-CoV-2 drives development of COVID-19</span><span class="source" tagx="source" title="source">Cell</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.cell.2020.04.026">10.1016/j.cell.2020.04.026</a></span><span class="comment">In press</span></span></li> <li tag="ref"><a name="bb0545" /><span class="label" tagx="label" title="label">109</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kozicky</span><span class="given-names" tagx="given-names" title="given-names">L.K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">Z.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Menzies</span><span class="given-names" tagx="given-names" title="given-names">S.C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fidanza</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Reid</span><span class="given-names" tagx="given-names" title="given-names">G.S.D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wilhelmsen</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Intravenous immunoglobulin skews macrophages to an anti-inflammatory, IL-10-producing activation state</span><span class="source" tagx="source" title="source">J Leukoc Biol</span><span class="volume" tagx="volume" title="volume">98</span><span class="year" tagx="year" title="year">2015</span><span class="fpage" tagx="fpage" title="fpage">983</span><span class="lpage" tagx="lpage" title="lpage">994</span><span class="pub-id"><a href="https://dx.doi.org/10.1189/jlb.3VMA0315-078R">10.1189/jlb.3VMA0315-078R</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26216934">26216934</a></span></span></li> <li tag="ref"><a name="bb0550" /><span class="label" tagx="label" title="label">110</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Meregalli</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Marjanovic</span><span class="given-names" tagx="given-names" title="given-names">I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Scali</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Monza</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Spinoni</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Galliani</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span></span><span class="mixed-article-title" title="mixed-article-title">High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats</span><span class="source" tagx="source" title="source">J Neuroinflammation</span><span class="volume" tagx="volume" title="volume">15</span><span class="year" tagx="year" title="year">2018</span><span class="fpage" tagx="fpage" title="fpage">232</span><span class="pub-id"><a href="https://dx.doi.org/10.1186/s12974-018-1270-x">10.1186/s12974-018-1270-x</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30131066">30131066</a></span></span></li> <li tag="ref"><a name="bib551" /><span class="label" tagx="label" title="label">111</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">Bin</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">Shuyi</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tan</span><span class="given-names" tagx="given-names" title="given-names">Tan</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">Wenhui</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dong</span><span class="given-names" tagx="given-names" title="given-names">Yuhao</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">Luyan</span></span></span><span class="mixed-article-title" title="mixed-article-title">Treatment With Convalescent Plasma for Critically Ill Patients With SARS-CoV-2 Infection</span><span class="source" tagx="source" title="source">Chest</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.chest.2020.03.039">10.1016/j.chest.2020.03.039</a></span><span class="comment">In press</span></span></li> <li tag="ref"><a name="bib552" /><span class="label" tagx="label" title="label">112</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rajendran</span><span class="given-names" tagx="given-names" title="given-names">Karthick</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Narayanasamy</span><span class="given-names" tagx="given-names" title="given-names">Krishnasamy</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rangarajan</span><span class="given-names" tagx="given-names" title="given-names">Jayanthi</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rathinam</span><span class="given-names" tagx="given-names" title="given-names">Jeyalalitha</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Natarajan</span><span class="given-names" tagx="given-names" title="given-names">Murugan</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ramachandran</span><span class="given-names" tagx="given-names" title="given-names">Arunkumar</span></span></span><span class="mixed-article-title" title="mixed-article-title">Convalescent plasma transfusion for the treatment of COVIDâ€�19: Systematic review</span><span class="source" tagx="source" title="source">J Med Virol</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1002/jmv.25961">10.1002/jmv.25961</a></span><span class="comment">In press</span></span></li> </ul> </div> <div class="ack" title="ack"> <div class="title" tagx="title" title="title">
Acknowledgements</div> <p>The authors thank all the members of the CREA and the â€œCP-Covid-19 Groupâ€� for contributions and fruitful discussions.</p> </div> </div>  </body></html>